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MAMMALIAN DCN-1-LIKE PROTEINS ENHANCE NEDDYLATION OF CUL3, AND VARY IN
LOCALIZATION AND TISSUE-SPECIFIC EXPRESSION.
Russell Ryan, Alex Kim, Yoshi Yonekawa, Lydia Choi, Andrew Kaufman, Y. Ramanathan, Lyann
Mitchell, KeumSil Hwang, Patricia Morris, and Bhuvanesh Singh. Section of Head and Neck Surgery,
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY. (Sponsored by Jeffery
Sklar, Department of Pathology, Yale University School of Medicine)
The Squamous Cell Carcinoma-Related Oncogene (SCCRO/DCUN1D1), located at 3q26.3, is a
candidate oncogene that is gene-amplified and overexpressed in squamous-cell carcinomas of the upper
aerodigestive tract and lung. The SCCRO protein is a member of a phylogenically conserved protein
family, the defective in cullin neddylation – 1 – like domain – containing (“Dcun1d”) proteins, which have
been shown to promote the covalent modification of cullin proteins by the ubiquitin-like protein Nedd8.
In this study, we sought to characterize the expression and molecular interactions of vertebrate Dcun1d
proteins, in order to better understand the normal function of genes in this family. We demonstrate that the
majority of SCCRO protein in cultured human epithelial cell lines is not found in stable complexes with
known interactors, including cullins, UBC12, and CAND1, a regulator of cullin–RING-finger ubiquitin
ligases (CRL’s). We show that SCCRO expression is not cell-cycle regulated in HeLa-S cells. We describe
five highly conserved vertebrate Dcun1d genes, and show that the products of all five genes interact with
cullins and with CAND1. We show that four of the five proteins enhance the neddylation of CUL3 in a
dose-dependant fashion in-vitro. We demonstrate that the UBA domain-containing SCCRO and Dcun1d2
proteins are pan-cellular in localization, while other family members contain alternate N-terminal domains
which mediate their exclusive localization to the nucleus (Dcun1d4 and Dcun1d5) or to cellular membranes
(Dcun1d3). We demonstrate that expression of alternate Dcun1d1 transcipts is specifically regulated in
mouse germ cells during spermatogenesis, and we present evidence for specific expression of Dcun1d2 in
brain and muscle tissue. We conclude that spermatogenesis and myogenesis could serve as valuable model
systems for future studies of the interaction between expression levels of vertebrate Dcun1d proteins and
the activity of CRL complexes. Such work could be valuable in understanding how SCCRO overexpression
contributes to cancer.
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Introduction
A.

The role of oncogenes in carcinogenesis

An oncogene is defined as “a gene whose protein product contributes to the development and / or
progression of cancer.”(1) The first oncogenes were identified as genes present in certain cancer-causing
retroviruses. Many of these viral oncogenes, such as v-Src and v-Myc, were found to have originated
through viral transduction of host genetic material, and the host genes from which they were derived were
designated “proto-oncogenes.” Viral oncogenes typically differ from their cellular counterparts in one of
two general ways. First, in comparison to proto-oncogenes, viral oncogenes often contain alterations in
their coding region, such as partial deletions or point mutations, resulting in protein products which possess
abnormal activity in comparison with their cellular counterparts. In the case of other viral oncogenes, their
juxtaposition with a powerful viral promoter leads to massive overexpression of the protein product in
infected cells. Thus, although the protein itself is functionally similar to those normally produced by the
cell, overexpression is sufficient to contribute to cellular transformation and tumorgenesis.

Very few human malignancies are thought to be caused by retroviral oncogene-mediated
transformation; rather, most carcinogenesis occurs as the result of series of DNA-damage events which
alter the tumor cell’s genome, causing the activation of cellular proto-oncogenes and the deactivation of
tumor-suppressor genes. However, as in retroviral oncogenes, oncogene activity in non-virally induced
tumors typically results from either coding-sequence alteration (through mutation or translocation) or
overexpression of cellular proto-oncogenes. Genetic alterations leading to proto-oncogene overexpression
include promoter translocations, mutations affecting transcriptional control regions or mutations in
sequences affecting transcript stability. Perhaps the most common means of proto-oncogene overexpression
in epithelial malignancies, however, results from the chromosomal instability and complex aneuploidy seen
in these tumors. As genomic rearrangements and abnormal mitoses produce some pre-malignant or
malignant cells with more than two copies of certain chromosomal regions, cells that gain additional copies
of proto-oncogenes may be further transformed, resulting in tumor progression.
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One of the major strategies employed in recent years to better understand the genetic basis of cancer
has been an effort to map recurrent regions of chromosomal copy number abnormalities (CNA’s) in
specific human malignancies. Loss of a chromosomal region is detectable through loss of heterozygosity
(LOH) analysis of marker loci, or through copy number determination via comparative genomic
hybridization (CGH), and may represent a “second hit” to one or more tumor suppressor genes at that
region. Gain of a chromosomal region may result in overexpression of many encompassed genes, and the
observation that a certain region is gained in many tumors of a certain type suggests that one or many genes
within that region have pro-oncogenic activity. Because of the large number of genes encompassed by

3p partial deletion

3q26

Introduction Figure 1: A schematic diagram of chromosome 3, along with experimentally determined
partial karyotypes of three cancer cell lines containing 3p partial deletion, 3q gain, and 3q26 amplification.
Adapted with permission from Darai-Ramqvist, E. et al., 2006.(13)
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chromosomal gains, it is difficult to use these findings alone to identify candidate oncogenes. Genomic
amplification (Introduction Figure 1) is a form of CNA in which a small chromosomal segment is
duplicated many times (often >10, occasionally >100 times), with copies present in tandem, on different
chromosomes, or on extra-chromosomal “double minutes.”(2) Powerful selective pressures act on
malignant and pre-malignant populations of cells, so despite the instability of these amplified genomic
regions, those which contain growth or survival enhancing genes are retained in the tumor. Since genomic
amplifications often contain fewer than 20 genes, identification of recurrent amplification peaks can be a
fruitful strategy for oncogene identification.

B.

The candidate oncogene SCCRO

Several tumor types originating from mucosal squamous-cell epithelium demonstrate a similar
recurrent gain of the long arm of chromosome 3, including head and neck squamous cell cancer
(HNSCC),(3) squamous-type non-small-cell lung cancer (NSCLC),(4) and cancer of the uterine cervix.(5)
Frequent gain of this region has also been reported in ovarian cancer. In the cervix, 3q copy number gains
or high-level amplification are found in 90% of invasive cancers, but are absent from nearly all premalignant dysplastic lesions.(6) Low-resolution mapping studies utilizing comparative genomic
hybridization (CGH) and spectral karyotyping (SKY) refined the region of frequent amplification in several
squamous cell carcinoma types to 3q25-27. With the use of fine resolution mapping, several candidate
oncogenes have been proposed as contributing to selection for this region in tumor progression. These
include PIK3CA(7, 8), PKCι(9, 10), LAMP3(11), eIF-5A2(12), and most recently, the squamous cell
carcinoma-related oncogene (SCCRO/DCUN1D1).

Our group identified SCCRO as a candidate oncogene through FISH-based fine-resolution mapping of
a region of maximal amplification at 3q26.3 in head and neck cancer cell lines.(8, 14, 15) Of the proteincoding genes predicted to exist within this amplification peak, only SCCRO was found to be highly
expressed in tumor cell lines. An overlapping region of recurrent amplification, containing SCCRO and
only 6 other genes, was noted in an independent SNP-chip based analysis of 101 lung cancer cell lines and
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primary tumors.(16) Both studies noted that PI3KCA, a well-characterized 3q26 oncogene, was present in a
separate and non-overlapping recurrent amplification peak.

SCCRO gene amplification correlates significantly with mRNA and SCCRO protein overexpression in
tissue and cell lines derived from head and neck and lung cancers. No mutations were identified in SCCRO
coding sequences from a large cohort of HNSCC and squamous NSCLC. In primary human tumors, highly
significant overexpression of SCCRO mRNA relative to normal tissue controls was noted in 36% of head
and neck, 44% of cervical, and 48% of non-small cell lung cancers tested. Of the latter group, 61% of
squamous cell cancers but only 9% of adenocarcinomas overexpressed SCCRO. Furthermore, SCCRO
overexpression was shown to correlate negatively with cause-free survival in non-small cell lung
cancer.(17)

Functional evidence of SCCRO’s oncogenic activity came from experiments in which SCCRO was
transgenically overexpressed in mouse fibroblasts and human immortalized keratinocytes. SCCROtransfected keratinocytes gain anchorage-independent growth, while stably SCCRO overexpressing
fibroblasts show dedifferentiated morphology, increased proliferation, serum-independent growth,
enhanced invasiveness, and tumorgenicity in nude mice.(14)

The term “oncogene addiction” refers to the phenomenon in which tumor cells are dependent on a
specific oncogenic signal in order to maintain cell survival and proliferation. Demonstration that a tumor is
“addicted” to the activity of an overexpressed or mutant protein is a strong demonstration of that protein’s
importance in an oncogenic pathway, and can also provide proof-of-principle for the concept of targeting
that pathway therapeutically. Importantly, knockdown of SCCRO protein levels via transfection of antiSCCRO RNAi constructs or antisense oligonucleotides resulted in decreased proliferation and increased
apoptosis of tumor cell lines, but only in lines which significantly overexpressed the SCCRO protein.(14)
This suggests that SCCRO overexpressing cancers are “addicted” to a SCCRO-dependant survival pathway.
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C.

SCCRO orthologs and the Dcun1d1-/- mouse.

The murine ortholog of SCCRO was first described in 2000 by two independent groups. Pourcel et al.
described expression of the gene, which they named Tes3, in a number of adult mouse tissues. They noted
very high-level expression of a number of alternate Tes3 transcripts in the testes only.(18) Mas et al.
identified the same gene, which they named Rp42, as part of an effort to characterize genes involved in
brain development.(19) They found that Rp42 transcripts were expressed in a developmentally regulated
manner in proliferating neuroblasts of the telencephalon and mesencephalon. Neither group reported on
functional properties of the protein product, although Pourcel et al. reported weak protein sequence
homology between TES3 and basic helix-loop-helix leucine zipper transcription factors.

Our group has generated a transgenic knockout mouse for Tes3/Rp42/Dcun1d1 (hereafter referred to as
Dcun1d1). The heterozygous mouse shows no significant abnormalities, while the Dcun1d1-/- mouse shows
increased perinatal mortality, variable growth retardation, and complete male infertility. The testes of
mature Dcun1d1-/- males become atrophic, with degeneration of seminiferous tubules and production of
few and often morphologically abnormal sperm.(20) In combination with the published patterns of
Dcun1d1 expression, these findings suggest a critical role for Dcun1d1/SCCRO in spermatogenesis.

D.

SCCRO interacts with CAND1 and cullins

In order to understand the cellular functions of the SCCRO protein, our group generated GST-SCCRO
fusion constructs and used GST pulldown to isolate SCCRO binding partners in lysate of the lung cancer
cell line SCC15 (Introduction figure 1a). These proteins were then identified using MALDI-TOF mass
spectrometry.(21) SCCRO was shown to interact with several proteins in the cullin family, which are
subunits of a class of ubiquitin ligase complexes. Also identified was an interaction between SCCRO and
CAND1, a well-characterized regulator of cullin activity. These findings, along with subsequent
experiments described below, strongly linked SCCRO’s function to the cullin–RING-finger family of
ubiquitin ligase complexes.
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CAND1
100KD

CUL1, CUL2, CUL3,
CUL4a, CUL4b

50KD
GST-SCCRO

SCCRO
(D241N)

b.

SCCRO
(L30A)

GST

SCCRO
(34-259)

(b) Specific interaction of GST-tagged
SCCRO and SCCRO mutants with
CDL-associated proteins in HeLa
lysate. Note that interactions with
CAND1, cullins, ROC1, and UBC12
are retained in the N-terminal truncated
SCCRO(34-259) and the UBA domain
mutant SCCRO(L20A). However, the
SCCRO(D241N) mutant loses binding
to the cullins and to the cullin-binding
CAND1 and ROC1, but not to the
NEDD8 E2 enzyme UBC12.

GSTGST SCCRO

SCCRO
(WT)

(a) Bacterially expressed GST and
GST-SCCRO were used for pulldown
of proteins from SCC15 lysate.
Following SDS-PAGE, the gel was
stained for total protein with coomassie
blue. Bands uniquely appearing in the
GST-SCCRO lane were excised and
identified via MALDI-TOF mass
spectrometry, which demonstrated the
presence of CAND1 and CUL1, CUL2,
CUL3, CUL4a, and CUL4b.

a.

GST
only

Introduction Figure 2: SCCRO
interacts with proteins in the cullin–
RING-finger ubiquitin ligase pathway.

a-CAND1

a-CUL1

a-CUL2

a-CUL3

a-CUL4a
a-CUL5

a-ROC1

a-UBC12

E.

An overview of cullin–RING-finger ubiquitin ligase complexes

The ubiquitin-proteasome system is a complex molecular system for regulating the degradation of a
wide variety of cellular proteins. Factors whose degradation is controlled by this system include cell-cycle
regulatory proteins, transcription factors, transmembrane growth-factor receptors, and components of signal
transduction pathways and other cellular processes. Ubiquitin itself is a small, phylogenically conserved
peptide, which can be covalently attached to a lysine residue on a target protein via an isopeptide bond with
its C-terminal glycine. This reaction is mediated by a three-enzyme cascade involving proteins or
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complexes with ubiquitin activating (E1), ubiquitin conjugating (E2), and ubiquitin ligase (E3) activities
(Introduction Figure 3). Poly-ubiquitin chains can be created through repeated activity of this cascade on a
target protein, leading to recruitment of that protein to the 26S proteosome for ATP-coupled
hydrolysis.(22)

U
U

E1

U

E2

E2

S

S
E3

a.

E1

E3

b.
U

E1

E1
U

E2

U

E2

U

S

S
E3

c.

U

E3
d.

Introduction Figure 3: A schematic diagram of the ubiquitination cascade. (a) Free ubiquitin (U) is
adenylated by an E1 enzyme, which allows for the formation of a thioester bond between ubiquitin and the
catalytic cysteine of the E1. E1 then associates with an E2 enzyme. (b) Ubiquitin is covalently transferred
from E1 to the reactive cysteine of E2, which then dissociates from E1 and binds to a substrate-bearing E3
enzyme. (c) The E3 mediates covalent transfer of ubiquitin to a target lysine on the substrate (S). (d)
Repeated cycles of the E1-E2-E3 cascade are required for the formation of a poly-ubiquitin chain on the
substrate, which is then recruited to the proteasome for degradation.
Specificity and regulation of the ubiquitination reaction are critical to prevent wasteful degradation of
proteins, and targeting of a specific protein for proteosomal degradation often occurs in response to a
precise cellular signal or event. This specificity is achieved through two general mechanisms. First, the
protein target is must be available and in a form that facilitates its recruitment to the ubiquitination
machinery. Many proteins are marked for ubiquitination by certain phosphorylation states, which in turn
are dependant on the regulated activity of kinases and phosphorylases. Binding to other proteins or non-
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peptide molecules, as well as localization to a specific subcellular compartment, may also affect the
availability of a given protein for ubiquitination. The second source of specificity and regulation in
ubiquitination lies in the E3 component of the cascade, which actually consists of hundreds of different
protein complexes, each of which may be specific for a small subset of protein targets. While the identities
of some of these complexes have been revealed in the past ten years, this is rapidly evolving field, and
many details of this system remain unexplored.

Cullin–RING-finger ubiquitin ligase complexes (CRL’s) represent one class of ubiquitin E3
complexes. Unlike other E3’s, such as the HECT domain and U-box E3’s, CRL’s do not appear to contain
specific catalytic residues which mediate the transfer of ubiquitin from the E2 to the target protein. Rather,
structural models of CRLs suggest that they facilitate this reaction by bringing into proximity separate
subunits that bind the ubiquitin-E2 conjugate and the target protein. In all CRL’s studied to date, a cullin
family protein forms an elongated backbone, with the RING-finger protein Roc1 (or a close homolog)
stably bound near the c-terminal end of the cullin protein.(23, 24) It is the Roc1 RING-finger domain which
appears to recruit the E2-ubiquitin conjugate. At the N-terminal end of the cullin protein is a domain which
recruits the substrate-binding protein, either directly or through an adaptor protein. It is the substratebinding protein which makes each CRL complex specific for a certain ubiquitination target.(25)

Six human cullin proteins; CUL1, CUL2, CUL3, CUL4a, CUL4b, and CUL5 are representatives of
five highly conserved metazoan cullin classes. In fact, four of the five classes appear to be functionally
conserved in organisms throughout the major eukaryotic taxa (Cul5 orthologs are restricted to metazoans),
underscoring the ancient role of the CRL system in the function of eukaryotic cells. The six human proteins
range in size from 87 to 104 kD. A class of larger, more divergent cullin homologs appears to be conserved
in terrestrial vertebrates, and is represented by two genes in mammals, Cul7 and Parc (p53-associated
parkin-like cytoplasmic protein). Another distant cullin homolog, Anapc2, is a component of a conserved
multimeric complex with E3 ligase activity, the anaphase-promoting complex / cyclosome. The following
discussion will focus on complexes formed by the five core classes of cullin proteins (Introduction Figure
4), with an emphasis on their known roles in carcinogenesis.
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S FBox

S FBox
Skp1

Roc1

Roc1

Ddb1

Cul4

Cul1
N

N

S VHLB

S SOCS
elB elC

elB elC

Roc2

Roc1

Cul2

Cul5
N

N

BTBP

S
Roc1

Cul3
N

Introduction Figure 4: Schematic model diagrams of CRL complexes formed by the five highly
conserved classes of cullin proteins. Each complex contains a characteristic cullin protein, a Roc protein, 02 adaptor proteins, and one member of a family of characteristic substrate-binding proteins (S = substrate).
The Nedd8 moiety (N) is covalently attached to the cullin protein in at least some active complexes from
all five classes. Substrate-binding protein classes are colored black and labeled as follows: FBox = F-box
protein, VHLB = VHL-box protein, SOCS = SOCS-box protein, BTBP = BTB protein. Adapted from
solved crystal structures for the SCF,(23) VBC,(26) and DDB1-Cul4a-Roc1 complexes,(24) and other
sources.
F.

Cul1 CRL complexes

The first, and most extensively characterized class of CRL complexes are those formed by Cul1
orthologs. These complexes contain Roc1 bound at the Cul1 C-terminal,(27) while the N-terminal of Cul1
binds to the adaptor protein Skp1. Skp1, in turn, binds to a substrate-recruiting F-box protein.(28, 29) A
bioinformatic analysis of predicted proteins in the human genome demonstrated the presence of 68 F-box
proteins in three broad classes (Fbxl, Fbxw, and Fbxo)(30), although only a handful are proven members of
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active Skp1-Cul1-F-box (SCF) complexes. Three of these, Skp2, Fbxw7, and β-Trcp, are particularly
noteworthy as regulators of critical pathways implicated in oncogenesis.(31)

Skp2 is the prototypical “F-box with leucine-rich repeat” (Fbxl) protein and serves as the substratebinding component of the SCFSkp2 complex. SCFSkp2 is responsible for the degradation of several critical
cell-cycle control regulators, including the CDK inhibitors p27Kip1(32), p57Kip2(33), and p21Cip1(34), as well
as the Rb family protein p130(35). Since these proteins are all known to have tumor-suppressing activity,
increased SCFSkp2 activity might be expected to be pro-oncogenic. In fact, SKP2 overexpression has been
observed in a wide range of human malignancies, including HNSCC(36, 37) and NSCLC(38), often in
concert with underexpression of a known SCFSKP2 target such as p27KIP1. It has also been shown to
contribute to oncogenesis in a variety of experimental systems.(37, 39-41)

In contrast to SCFSkp2, SCF complexes containing the F-box protein Fbxw7 (orthologs cdc4p and
archipelago) seem to target a number of growth-promoting proteins for ubiquitination, including
phosphorylated cyclin E,(42) certain members of the notch family of signaling proteins,(43) and c-Myc.(44,
45) Fbxw7 inhibition leads to chromosomal instability,(46) possibly through mechanisms involving Cyclin
E or Aurora A. Support for the status of FBXW7 as a tumor suppressor gene comes from the observation of
FBXW7 mutation or deletion in several human tumors.(47, 48) Also, Fbxw7 haploinsufficiency cooperates
with p53 haploinsufficiency to produce epithelial tumors in an irradiated mouse model.(49)

β-Trcp (SLIMB in Drosophila) is a third well-characterized F-box protein, and the prototype of the Fbox with WD-40 repeat (Fbxw) family. SCFβ-Trcp has activities which could potentially be pro- or antioncogenic, depending on the cellular context. SCFβ-Trcp activity is necessary for degradation of the growthpromoting Wnt pathway mediator β-catenin,(50, 51) which is activated in many human tumors. BTRC is
not thought to be a frequently altered tumor suppressor in human carcinogenesis, however, since loss of
expression of two paralogous β-Trcp genes (BTRC and BTRC2) would have to occur in order for this
activity to be lost in an evolving tumor(52). In addition, SCFβ-Trcp positively regulates the pro-survival
activity of the NF-κB pathway by targeting IκB for ubiquitination.(53, 54).
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G.

Cul4 CRL complexes

All Cul4-containing complexes studied to date, (including both Cul4a and Cul4b complexes in
humans) contain Roc1 and the Cul4 C-terminal binding protein Ddb1. Recently it has been shown that Cul4
orthologs share several targets with Cul1, and may even utilize some of the same F-box proteins for adaptor
recruitment. For example, mammalian Cul4a-Roc1-DDB1 has been shown to bind Skp2 and mediate
ubiquitination of p27Kip1.(55) Another apparent target of a Cul4a CRL which is shared with a Cul1 CRL is
the replication licensing factor Cdt1(56, 57). Since Cdt1 expression in S phase is an important regulator of
chromosomal stability, overexpression of Cul4a could theoretically promote the chromosomal instability
phenotype common in epithelial malignancies. Cul4a also mediates ubiquitination and degradation of two
proteins involved in the nucleotide excision repair pathway, Ddb2 and Csa(58). These findings are
important, because unlike CUL1, there is direct evidence that CUL4A may act as a true oncogene, with
transcript overexpression seen in 47% of primary breast cancers(59) and amplification of the CUL4A
chromosomal locus seen in breast cancers, hepatocellular carcinomas, esophageal squamous cell
carcinomas, and other tumor types(60).

H.

Cul2 and Cul5 CRL complexes

All known Cul2 CRL complexes contain two common adaptor proteins, elongin B and elongin C,
which bind at the Cul2 N-terminal in a position analogous to that of Skp1 in the SCF complex.(26) The
substrate-binding adaptors in Cul2 complexes, called elongin B and C binding proteins (BCBP’s), generally
contain a short conserved motif known as a BC box.

The most extensively studied of the Cul2 complex adaptor proteins is the von Hippel-Lindau tumor
suppressor protein (vHL). Under normoxemic conditions, vHL recruits the transcription factor Hif-1α to
the so-called VBC complex, where it is ubiquitinated and rapidly degraded.(61-63) Low oxygen tension
causes a decrease in the affinity of Hif-1α for vHL, resulting in Hif-1α accumulation and formation of a
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Hif-1α - Hif-1β heterodimer. The heterodimer activates transcription of hypoxia-inducible genes, which
may enhance cellular survival and proliferation. Thus, genetic loss of vHL, or other disruption of the Cul2 vHL - elongin B - elongin C (VBC) complex leads to constitutive activation of an oncogenic pathway. A
“second hit” loss of the remaining VHL gene is responsible for the development of vascular malformations
and tumors in the von Hippel-Lindau familial tumor syndrome in humans, and homozygous inactivation of
VHL also contributes to the development of sporadic renal cell carcinoma.(64)

Interestingly, Cul5 also forms complexes containing elongin B and elongin C, along with a repertoire
of BCBP’s which seems to partially overlap those involved in Cul2 complexes. Many Cul5-binding
BCBP’s contain a second conserved sequence downstream of the BC box, with the combination of those
two elements defining a so-called SOCS box.(65) Cul5-containing CRL’s are also unique in containing
Roc2, rather than the Roc1 found in other cullin complexes.(65, 66)

I.

Cul3 CRL complexes

Cul3-containing CRL’s differ from those of other classes in that they contain a substrate-binding
protein from the BTB family, which binds directly to the Cul3 c-terminal, rather than to an adaptor protein.
Thus, a single BTB protein serves the functions played by Skp1 and an F-box protein in the SCF
complex.(67) Based on gene sequence analysis, as many as 183 BTB proteins may exist in the human
genome,(68) representing one of the most diverse classes of human CRL adaptors, although it is likely that
not all proteins containing a BTB domain are true components of Cul3-based E3’s. Interestingly, several
Cul3-interacting BTB proteins seem to exist primarily as homodimers with multiple distinct Cul3
interacting domains, supporting the notion that active Cul3 CRL’s may contain more than one Cul3
molecule.(68)

Several noteworthy Cul3-BTB complexes have been described. In the early C. elegans embryo, a
CUL-3 CRL containing the BTB protein MEL-26 appears to be responsible for the degradation of MEI-1, a
microtubule-severing protein expressed during meiosis. Interference with MEL-26 or CUL-3 function leads

16

to abnormal mei-1 accumulation in the mitotic cycle which follows meiosis, resulting in abnormal mitotic
spindle formation.(69) It has also been suggested that Cul3 plays a major role in mammalian reproduction,
based on the greatly increased expression of Cul3 in adult mouse testes, along with Klhl-10, the gene
coding for a BTB protein binding partner.(70) Male Klhl-10-/- mice are infertile due to disrupted
spermatogenesis.

Another important BTB protein, the Drosophila roadkill (RDX) protein, has recently been shown to
control the Cul3-dependant degradation of the important hedgehog pathway mediator cubitus interruptus
(CI) in several developmental contexts.(71, 72) The vertebrate Rdx ortholog, Speckle-type POZ Protein
(Spop), appears functionally similar to Rdx, although it is not yet clear that it has a homologous role in
controlling the vertebrate hedgehog pathway. Interestingly, in other developmental contexts, CI is degraded
by a CUL1-dependant mechanism.(73)

The hedgehog pathway is not the only example of a developmental signaling pathway controlled by
both Cul1 and Cul3 SCL’s. An SCL containing Cul3 and the BTB protein Klhl-12 appears to be
responsible for negatively regulating the β-catenin pathway by mediating ubiquitination of the WNT
pathway intermediate Dishevelled.(74) Both the hedgehog and Wnt-β−catenin pathways have been referred
to as “onco-developmental” pathways due to their involvement in a range of human malignancies, raising
the possibility that Cul3 complexes could have undiscovered tumor-suppressing or tumor-promoting roles.

J.

Parc and Cul7 complexes

Parc and Cul7 are homologous cullin-like proteins which are conserved in mammals, and are
similar to proteins found in Gallus gallus and Xenopus tropicalis. Human CUL7 has been shown to form
SCF-like complexes containing ROC1, SKP1, and the F-box protein FBXW8. Unlike other cullins,
however, Cul7 does not appear to undergo modification with the ubiquitin-like protein Nedd8. It has also
been shown to form heterodimeric complexes with Cul1. Parc, on the other hand, does undergo Nedd8
modification, but does not interact with Skp1 or known F-box proteins.(75) It forms heterodimeric
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complexes with Cul7 which appear to possess ubiquitin ligase activity(76). Both Cul7 and Parc are notable
in that they possess conserved CPH domains which bind the tetramerization domain of the important tumor
suppressor protein p53,(77) however, their effect on p53 function is poorly understood.

K.

Cullin neddylation and regulation of CRL activity

Members of the five conserved cullin classes can be isolated from most cells in two forms: a
monomeric form, and a higher molecular weight form which has been shown to represent a covelent
conjugate of the cullin with a small ubiquitin-like protein called Nedd8.(78-80) Unlike ubiquitin, Nedd8
does not form long, polymeric chains on the target proteins, and cullin proteins appear to be the primary, if
not exclusive target of “neddylation.” Cullin neddylation occurs through a process similar to that of
ubiquitination. The vertebrate enzymes specific for neddylation are the heterodimeric complex Appbp1Uba3 (E1) and Ubc12 (E2).(81) The existence or identity of an “E3” for neddylation has been
controversial, and will be further discussed below.
In contrast to ubiquitination, neddylation does not appear to mark proteins for degradation. Instead,
neddylation has been shown to facilitate activity of CRL complexes in several contexts. The neddylation
system was first studied in S. cerevisiae, where deletion of the Nedd8 ortholog or its E1 enzyme was found
to have no effect on cell growth or viability. Effects were only seen in synthetic mutants: when elimination
of the neddylation pathway was combined with a temperature-sensitive mutant of an SCF-related protein,
such as the Cul1 ortholog cdc53p, the ubiquitin E2 cdc34p, the Fbxw7 homolog cdc4p, or skp1p, lowering
of the temperature restrictive for growth was observed.(79) This suggested that cullin neddylation helps to
stabilize the CRL complex, and that in the absence of this stabilizing component, structurally unstable
mutant subunits were no longer able to maintain complex activity.

In contrast to the findings in S. cerevisiae, interference with the neddylation pathway alone results in
non-viability in S. pombe(82), and defective embryogenesis in C. elegans(83, 84) and in vertebrates(85).
Interference with the neddylation pathway prevents ubiquitination of specific mammalian SCF targets in
vitro(86), and in vivo(87, 88), as well as certain VBC targets in vitro and in vivo.(88)
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There have been several proposed explanations for why cullin neddylation is required to maintain CRL
activity in many organisms (Introduction Figure 5). One explanation comes from the finding that
neddylation of cullin proteins removes them from inhibition by Cand1/Tip120a, a 120 kD protein which
binds only to un-neddylated cullins.(89, 90) Structural studies have shown that Cand1 binding sites on Cul1
overlap those utilized by Skp1; thus, Cul1 cannot form an active SCF complex when in complex with
Cand1.(91) The absence of Cand1 homologs in S. cerevisiae could explain the apparently reduced
importance of neddylation in that species. Other proposed mechanisms by which neddylation might
enhance CRL activity include improved recruitment of the ubiquitin-E2 conjugate to the CRL complex(89),
and facilitation of cullin heterodimer formation.(93)

S FBox

Neddylation:
Mediated by APPBP1Uba3 [Nedd8-E1] and
Ubc12 [Nedd8-E2]

Skp1

Roc1

Cul1
N

Enhances Ubiqutin-E2
recruitment

Mediated by CSN
Allows Cand1
binding

Prevents Cand1
binding
Enhances Skp1
binding

Deneddylation:

Prevents
ubiquitination of
substrate-binding
proteins

Roc1

Cul1
Cand1

Introduction Figure 5: Diagram showing the role of neddylation and deneddylation in cycling Cul1
between the active SCF complex and the inactive Cand1-Cullin complex. Both neddylation and
deneddylation activities are required for continued activity of CRL complexes in vivo.
Several isopeptidases have been identified which are capable of removing Nedd8 from cullin
proteins.(94-96) The most physiologically important of these appears to be the COP9 signalsome (CSN), a
multi-protein complex with homology to the proteosome lid. One of the subunits of the CSN, Csn5/Jab1,
contains a metalloprotease domain which catalyzes cleavage of the cullin-nedd8 isopeptide bond.(97) This
function appears to be conserved in S. cerevisiae, despite the absence of orthologs to CSN subunits other

19

than Csn5.(96) Model organisms with defective CSN activity accumulate neddylated cullins,(96, 98).
Addition of purified CSN to in vitro reactions of SCFSkp2-dependant ubiquitination result in deneddylation
of Cul1 and decreased ubiquitination of p27Kip1.(99)

While the deneddylating activity and in-vitro effects of CSN suggest that it might act as an inhibitor of
CRL-dependant ubiquitination, in-vivo studies show a more complex picture. Genetic studies in model
organisms have demonstrated that CSN is actually necessary for the ubiquitination activity of certain
CRL’s, and deletion of CSN results in the accumulation of CRL substrates.(97, 98). These findings have
since been extended to mammalian systems – for example, heterozygous deletion of Csn5 in mice leads to
reduced p27 degradation.(100) The phenomenon of CSN inhibiting CRL activity in vitro, but facilitating
ubiquitination in vivo, is sometimes referred to as the “CSN paradox.” Interestingly, a similar phenomenon
is observed with Cand1, since knockout of that known CRL inhibitor also seems to reduce, rather than
increase CRL activity.(90)

The CSN paradox could be explained if continuous cycles of neddylation and deneddylation were
required in order to maintain CRL activity.(101) Some studies have indicated that continuous activation of
individual CRL complexes occurs in the absence of deneddylating activity, and that this results in autoubiquitination and degradation of CRL components such as F-box proteins, resulting in the observed
decrease in global CRL activity.(100, 102) Recently, a new model was proposed, based on experimental
evidence that at least some CRL complexes contain a heterodimer of one neddylated and one un-neddylated
cullin subunit. In this model, neddylation pathway aberrations which result in either all neddylated or all
un-neddylated cullins would prevent heterodimer formation, and thus, CRL activity.(93) These two models
need not be mutually exclusive, and regardless of the mechanism, it is empirically clear that there is a
critical but non-linear relationship between cullin neddylation and the activity of CRL-dependant
ubiquitination pathways.
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L.

DCN-1 and SCCRO have Nedd8 E3-like activity

Our group’s observation that SCCRO protein binds to all of the classic human cullins, as well as to
CAND1, suggested that the SCCRO proto-oncogene might play a role in the regulation of cullin activity.
Independently, Kurz et. al. identified the SCCRO ortholog dcn-1 (defective in cullin neddylation) while
screening C. elegans embryos for mutants which recapitulated phenotypic defects seen in Cul-3 and
neddylation pathway mutants.(103) They found that protein extracts from C. elegans dcn-1(-) mutants
show a significant decrease in the fraction of neddylated cul-3 compared to wild type embryos.

Kurtz et. al. also studied the orthologous gene dcn1 in S. cerevisiae, and found that deletion of dcn1 led
to a decrease in the fraction of neddylated cdc53p. Conversely, overexpression of dcn1p in yeast led to
increased neddylation of cdc53p. Through analysis of double mutants of dcn1 and other genes involved in
neddylation or deneddylation, they demonstrated that dcn1p functions by enhancing neddylation, rather
than by interfering with deneddylation. These changes in the neddylation state of cdc53p were functionally
significant because either deletion or overexpression of dcn1 lowered the restrictive temperature of
temperature-sensitive cdc53-1 mutants, suggesting that either an excess or a deficit of dcn1p-mediated
neddylation activity could interfere with cullin function. Finally, they showed that addition of yeast extract
from transgenic dcn1 overexpressing strains enhanced cdc53p neddylation in vitro to a greater extent than
did extract from dcn1 defective strains. They speculated that dcn1p may act as part of the E3 ligase for
neddylation, although they found that cdc53p neddylation was not enhanced by the addition of bacterially
expressed dcn1p to an in vitro reaction containing minimal purified components, suggesting that additional
factors were needed for this activity.

Investigations by other members of our group, performed contemporaneously with the current work,
have produced significant additional evidence for the importance of SCCRO in the neddylation of human
cullin proteins. The addition of purified, bacterially expressed SCCRO to in vitro reactions utilizing
purified Nedd8, E1 and E2 enzymes, ATP, and mammalian cell lysate results in dose-dependant
enhancement of the rate of CUL3 neddylation. This effect is abrogated in c-terminal truncated SCCRO
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proteins or the mutant SCCRO(D241A), both of which lack cullin-binding capability. Conversely, in vitro
neddylation reactions performed with lysate from Dcun1d1-/- mouse tissues produce significantly less
CUL3 neddylation compared to reactions performed with wild-type lysate. These findings are analogous to
those made for Dcn1p, and strongly suggest that SCCRO acts as a molecular activator of cullin
neddylation. However, attempts to extend these findings in vivo by overexpressing SCCRO or performing
RNAi-mediated SCCRO knockdown in cultured mammalian cells have not, to date, yielded consistent
changes in the level of neddylated cullins or ubiquitination activity.

M.

Understanding the function of SCCRO – implications for cancer

Due to the complexity of the CRL system, and our incomplete understanding of the function of the
neddylation pathway, it is difficult to make a priori hypotheses about the mechanism by which SCCRO
overexpression contributes to tumor development. As described in this introduction, there are a wide
variety of potentially oncogenic and tumor-suppressing pathways which are known to be affected by
specific CRL E3 complexes, and an even greater number likely remain uncharacterized. One strategy for
approaching the mechanism of SCCRO-mediated oncogenicity would be to individually assay each of the
many “candidate” CRL complexes and ubiquitination targets for altered activity in SCCRO-overexpressing
tumors or SCCRO-transformed cell lines. Another approach, and the one which inspired the current work,
would be to identify specific cellular processes or tissues in vertebrates which are dependant on SCCRO or
SCCRO-like proteins for their normal function. By learning more about the endogenous role of SCCRO, it
might be possible to more rationally focus future studies of SCCRO’s role in carcinogenesis.
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Statement of purpose

The central hypothesis of our research program has two parts. First, we believe that SCCRO acts as an
oncogene in carcinoma of the human lung and upper aerodigestive tract, contributes to selection for
chromosomal amplification at 3q26 during tumor evolution, and leads to a more aggressive tumor
phenotype when overexpressed. Second we hypothesize that the oncogenic effects of SCCRO are mediated
through an alteration in the activity of one or more cullin–RING-finger ubiquitin ligase complexes, thus
altering the ubiquitination-dependant degradation of one or more critical protein targets within the tumor
cell.

While we have published substantial evidence to support the first statement, demonstration of the
second poses a greater technical and theoretical challenge, given the multitude of CRL’s and potential CRL
ubiquitination targets. The purpose of this work is to characterize features of the normal expression and
molecular function of Dcun1d proteins in both cellular and tissue-based contexts, with the goal of
prioritizing specific endogenous processes which might be regulated by high expression of SCCRO or
related proteins. We expect that these endogenous functions of SCCRO would involve regulation of CRL
complexes, and could serve as valuable model systems for understanding the role of SCCRO
overexpression in epithelial malignancies.
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Methods

Gel filtration analysis of HaCaT, HeLa, and SCC15 lysates

HaCaT and HeLa cell lines, obtained from ATCC, were grown in minimal essential media (MEM)
supplemented with 10% fetal calf serum (FCS), using standard mammalian cell culture conditions and
techniques. Intact cells were removed from the plate via incubation in 0.25% trypsin + 1mM EDTA in
Hank’s Buffered Saline Solution without Mg2+ or Ca2+. Following trypsin neutralization with media, cells
were washed 2x in cold PBS, pelleted, and lysed via sonication in 2-3 volumes of FPLC buffer, consisting
of 20 mM HEPES*KOH, pH 7.5, 5 mM KCl, 0.75 mM MgCl2, 100 mM NaCl, 0.5 mM DTT, 1 mM
PMSF, and 10% glycerol by volume. Lysates were centrifuged at maximum speed in a tabletop
microcentrifuge, followed by ultracentrifugation at 50,000 g for 30 minutes to remove particulate matter.

Gel filtration was performed via FPLC on a Superose 6 column. 200 mcl of molecular weight standard,
purified protein solution, or cell lysate were loaded onto the system in FPLC buffer running at 0.35 ml/min,
with fractions collected continuously over 0.72 minute intervals. The void volume (V0) was defined as the
peak elution volume of blue dextran, which was measured through colorimetry. Elution volume for
standards and purified proteins was determined by SDS-PAGE and Coomassie blue staining of successive
fractions. A standard curve of Kav versus apparent molecular mass was determined by measuring the elution
volume Vr for low and high molecular mass protein standards (Amersham), calculating Kav = Vr–V0 / Vc–
V0 for each standard, and plotting Kav vs. log[Mr] where Mr is the known apparent molecular mass of the
standard. The curve was approximately linear at R2 = 0.95 over the range of standards from Mr = 13.7 –
669 kD.

For detection of specific proteins by western blot, aliquots of appropriate fractions were denatured for
3 minutes at 90ºC in Laemmli buffer, loaded onto an appropriate gel for SDS-PAGE (Criterion or Readygel systems, Bio-Rad) transferred to PVDF membrane (Immobilon-P, Millipore), blocked for at least 30
minutes in PBST (phosphate buffered saline + 0.05% Tween 20) + 5% powdered milk, incubated with
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appropriate primary antibody for 1 hour in PBST + 1% milk, washed for 15 minutes in PBST, incubated for
30 minutes with an appropriate HRP-conjugated secondary antibody in PBST + 1% milk, washed for 15
minutes in PBST, and imaged using the EC chemiluminescent kit (Millipore) and darkroom film exposure.
The polyclonal antibody used for detection of SCCRO was previously described(14) and recognizes an
epitope in the c-terminus of the SCCRO protein. Other utilized antibodies include anti-CUL1 (Zymed),
anti-CUL2 (Abcam), anti-CUL3 (BD), anti-CUL4 (Santa Cruz), anti-CUL5 (Santa Cruz), anti-Tip120a
(BD), anti-UBC12 (Rockland), anti-cyclin A (Santa Cruz), anti-p21 (Pharmigen), anti-α-tubulin
(CalBiochem), and anti-HA (Convance).

HeLa-S elutriation and FACS analysis
HeLa-S cells were grown in a spinner flask in Dulbecco’s modified Eagle’s medium (high glucose,
with L-glutamine) plus 10% fetal calf serum, penicillin, and streptomycin. Cells were maintained under
standard mammalian cell culture conditions at a density of 2 – 8 x 105 cells per ml. Centrifugal elutriation
was performed using a Beckman J2-21 M centrifuge and a JE-6B rotor with a large (40 ml) separation
chamber. Four liters of media containing 6 x 105 cells per ml were concentrated via centrifugation into a
total volume of 20 ml of cells and ice-cold fresh media. The cells were loaded into the centrifuge spinning
at 1600 rpm in a continuously pumped stream of ice-cold PBS without Mg2+ or Ca2+ and supplemented
with 1% FCS. A total of 10 fractions were collected from the centrifuge outflow according to a previously
validated algorithm of stepwise increases in PBS flow or decrease in rotational velocity of the centrifuge.
10 mcl of the load cell mixture and 10 ml of each fraction were immediately spun down and frozen at -80ºC
for later FACS analysis. Simultaneously, the bulk of cells from each fraction were spun down and frozen at
-80ºC for subsequent lysate preparation. Lysates of thawed cell fractions were prepared in FPLC buffer as
above.
FACS analysis was performed by fixing aliquots of thawed cells in ethanol and incubating for 30 min
at 37°C in 0.5 ml of staining solution (25 µg/ml propidium iodide and 10 µg/ml RNase A in PBS). Stained
cells were analyzed for DNA content using a Becton-Dickinson FACScan flow cytometer.
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Gel filtration of fractions F3, F6, and F8 was performed as above. SDS-PAGE of gel filtration
fractions was performed on two separate gels. These were then cut horizontally and the halves rearranged
prior to transfer such that all regions to be probed with the same antibody were transferred to a single
membrane. The remainder of the western blot protocol was performed as above.

Detection, phylogenetic, and sequence analysis of Dcun1d genes

Dcn1-like domain-containing genes were identified in H. sapiens, M. musculus, R. norvegicus, G.
gallus, D. rerio, D. melanogaster, C. elegans, S. cerevisiae, S. pombe, A. thaliana, and O. sativa using
publically available sequences in Genbank and analysis tools on the NCBI website, including protein-tonucleotide translated BLAST against expressed sequences, predicted transcripts, and genomic sequences
(See Appendices A and B for representative sequences). Expressed sequence evidence for predicted genes
was inspected against genomic loci using Map Viewer and the UCSC genome browser
(http://genome.ucsc.edu). Where incomplete or inconsistent expressed sequence evidence was present,
genomic sequences and homology to genes in other organisms were used to choose the best full-length
coding sequences. Due to ongoing addition of expressed sequence data, and automated and curated gene
prediction, nearly all genes identified over the course of this work have since been independently annotated
in NCBI and ENSEMBL databases in a manner consistent with our predictions, and the current NCBI gene
nomenclature was adopted in writing this manuscript.

Multi-alignment of nucleotide and protein sequences were performed and graphically plotted with the
ClustalX program(104) using the Gonnet matrix for amino acids. Refinements (primarily gap-reduction)
were performed manually using the GenDoc program (available at http://www.psc.edu/biomed/genedoc/).
Sequences for the human Dcn1 domain-containing genes were submitted to the PredictProtein server(105)
for identification of functional domains, non-regular secondary structure regions, localization signals and
other conserved domains. The “MYR predictor” was used for secondary analysis of putative Nmyristoylation signals (http://mendel.imp.ac.at/myristate/ SUPLpredictor.htm).(106)
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Acquisition and subcloning of murine Dcun1d genes

cDNA sequences corresponding to intact murine dcn1-domain containing transcripts were identified in
the database of the RIKEN consortium’s Functional Annotation of the Mouse 3 (FANTOM3) transcriptome
sequencing project(107), and sequence-verified cDNA clones were obtained (DNAform, Tokyo Japan – see
Appendix A for a complete list). The coding sequences of the five genes were then subcloned, using
standard PCR-based directional cloning techniques, into pEGFP-N2, pEGFP-C2 (Clontech), pGex-4T3,
and phCMV3 (Genlantis). Site-directed mutagenesis of Dcn1d3 was accomplished via PCR cloning with a
single-nucleotide mismatch encoding the mutation contained within the forward primer. All constructs
were sequenced prior to use to verify proper insertion and PCR fidelity.

Expression of Dcun1d constructs and fluorescent microscopy

HeLa cells were grown as above and transfected with appropriate gene-bearing or control plasmids
using Lipofectamine 2000 (Invitrogen) per the manufacturer’s specifications. For western blot, cells were
lysed on the plate 24 hours after transfection in Mammalian Cell Lysis Buffer (Cell Signalling) containing
20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, and 1 ug/ml leupeptin.

Cells transfected with EGFP vectors were digitally imaged 24 hours after transfection with a Nikon
IX51 fluorescent microscope using standard excitation and filter settings for eGFP fluorescence.

Expression and purification of Dcun1d proteins in E. coli

Cultures of protease-deficient E. coli (strain BL21, Novagen) bearing the appropriate pGEX-4T3
vector were grown from starter culture in LB + ampicillin in a 37ºC shaker. Cultures were grown for 3
hours pre-induction, followed by addition of IPTG to 1 mM and 3 hours of post-induction growth. Bacteria
were harvested by centrifugation and resuspended in PBS containing 1 mg/ml lysozyme, 5 mcg/ml
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DNAase, 5 mcg/ml RNAase, and protease inhibitor cocktail. The bacteria were lysed on ice through
repeated sonication over 30 min, and insoluble material was removed via centrifugation. The supernatant
was inverted with glutathione-sepharose resin at 4ºC for 40 minutes. The beads were washed 3 times with
bacterial bead-wash buffer containing 50mM Tris-Cl, pH 8.0, 150mM NaCl, 2.5mM MgCl2, 0.5% NP40, 1
tablet Complete Mini Protease Inhibitor (Roche) / 50 ml, 2.5 mM DTT, 0.2 mM PMSF, and 0.03% SDS,
followed by 2 washes and resuspension in PBS. The beads were incubated with thrombin overnight at 4ºC
to cleave the gene product from the GST moity. The supernatant was removed, protein concentrations
measured by colormetric assay (Bio-Rad protein assay, Bio-Rad) and sample purity and relative
concentration were verified via SDS-PAGE electrophoresis and Coomassie blue staining. Purified proteins
were diluted to appropriate concentrations in PBS + 5% glycerol and stored at -80ºC in single-use aliquots.

GST pulldown of Dcun1d protein binding partners

Lysates of bacteria expressing GST or GST-tagged Dcun1d proteins were prepared as above and were
incubated with equal aliquots of glutathione-sepharose beads, which were washed 3 times in bacterial beadwash buffer, followed by 2 washes with PBS. Volumes of HeLa lysate containing 500 mcg of protein were
added to each aliquot of beads and inverted at 4ºC for 1 hour. Beads were then washed 5 times in a buffer
containing 20 mM Tris-Cl, ph 8.0, 150 mM NaCl, 0.5% Np40, 1 tab complete mini PI / 50 ml, 2.5 mM
DTT and 0.2 mM PMSF. The beads were then boiled for 2 minutes in 1x Laemmli buffer, and equal
volumes of supernatant were loaded for SDS-PAGE and Western Blot as above. A second SDS-PAGE gel
was stained with Coomassie blue to verify that equivalent concentrations of GST or GST-Dcun1d proteins
were present in each sample.

In-vitro neddylation reactions

In-vitro neddylation reactions were performed in 50 mcl reactions containing 10 ng APPBP1 (Boston
Biochem), 20 ng UBC12 (Boston Biochem), and 5 mcg Nedd8 protein (Boston Biochem), 4 mcM ATP, 50
mcg HeLa-S lysate, 100 mM Tris HCl pH 7.45, 4.4 mM Na F, 110 mM NaCl, 24 mM MgCl2, 4 mM CaCl2
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and 20 to 1000ng of the appropriate bacterially expressed, purified Dcun1d protein. Reactions were
prepared on ice, incubated simultaneously at 37°C for 10-15 minutes, and stopped by addition of 10 mcl of
6x denaturing Laemmli buffer. 20-30 mcl of each reaction was then run on a 7.5% Criterion SDS-PAGE
gel (Bio-Rad), transferred to PVDF membrane, and probed with appropriate antibodies.

RNA extraction and Northern Blot

Total RNA was extracted from 100 mg of flash-frozen mouse tissue, using the Qia-shredder system
(Qiagen) for homogenization of tissue in Trizol reagent (Invitrogen). RNA was extracted using the Trizol
manufacturer’s protocol and was then further purified using the RNeasy kit with on-column DNAase
digestion (Qiagen). RNA was frozen in single-use aliquots and samples were submitted for quality
assessment with an Agilent Bioanalyzer system through the Sloan-Kettering Institute Microarray core
facility.

Northern blot was performed using the Northern Max Gly kit (Ambion) according to the
manufacturer’s instructions, with 15 mcg total RNA loaded per lane and transferred to a positively charged
nylon membrane (Roche).
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P – labeled probe was prepared using the Strip-EZ PCR kit (Ambion),

appropriate PCR primers, and a plasmid bearing murine Dcun1d1 cDNA (RIKEN clone F630119O03) as a
template. Excess nucleotide was removed from the
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P-labeled PCR product using Probequant G-50

microcolumns (Amersham), and specific radioactivity of the probe was quantified using a scintillation
counter. Following hybridization and washing, membranes were wrapped in plastic wrap and visualized
with a phosphorimager screen and a Storm phosphorimager reader (GE).

RT-PCR and quantitative RT-PCR

RT-PCR for Dcun1d gene transcripts was performed with primer pairs designed using the Primer3
program (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www_slow.cgi).(108) All primer pairs except
for mDcun1D1_RT2 crossed at least one splice junction to minimize mispriming on contaminating
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genomic DNA, and were designed to minimize homology with related genes. Primer pairs encompassing
the full predicted coding sequence of each of the murine Dcun1d paralogs were constructed to verify the
existence of full-length transcripts for each gene in mouse tissues.

Primer pairs for SYBER Green quantitative RT-PCR were designed to produce products from 75-150
bp in length. Where Genbank expressed sequence data or non-quantitative RT-PCR of the full coding
sequence suggested the existence of alternate transcripts with truncated coding sequences, primer pairs
were designed to straddle splice junctions which existed only in the full-length transcripts. Locations of
primer pairs on murine Dcun1d transcripts are diagrammed in Figure 7 (Results).

Primer pairs used for SYBER green quantitative RT-PCR:
mDcun1D1_RT2_F:
mDcun1D1_RT2_R:

GAAGGGCACACTCACTCACA
GAGACCTGACCCACACGAAG

mDcun1D1_RT3_F:
mDcun1D1_RT3_R:

TGGAATCTTCTGTTAGACTTCAGTTC
TGTTGTACTTTTTGTCCCAGCA

mDcun1D1ex1_RT1_F:
mDcun1D1ex1_RT1_R:

GGAGGAGGAGGGGAGAGG
TTGTGTGAAGATCATAAACTGACG

mDcun1D1ex1AB_RT1_F:
mDcun1D1ex1AB_RT1_R:

TGACAGACTGGCTCTGAACAA
CATTTTGAGAAAGACAACTTACTGC

mDcun1D1ex1C_RT1_F:
mDcun1D1ex1C_RT1_R:

GCAGTCCTTCCTTCAGCTTC
TGCAGTTTTCTCACTAGATTGTGT

mDcun1D2_RT1_F:
mDcun1D2_RT1_R:

CTAAGAACCCTGGGCAGAAG
TGATGCTCCAGCAGAAATGT

mDcun1D3_RT1_F:
mDcun1D3_RT1_R:

GAATTTCGAGTGCTGCTCTT
ACAGATCCCATCAATGCTGT

mDcun1D4_RT2_F:
mDcun1D4_RT2_R:

CAACACTGGCAAGCATTCAT
AGTCCGAAGAACTGCAAGAG

mDcun1D5_RT1_F:
mDcun1D5_RT1_R:

AGAACAGTTCATGCCGATCTT
AGGTTTGCATTGTCTTCACG

m18s_F:
m18s_R:

GTAACCCGTTGAACCCCATT
CCATCCAATCGGTAGTAGCG

mGAPDH:
mGAPDH:

TGCACCACCAACTGCTTAGC
GGCATGGACTGTGGTCATGAG
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cDNA was prepared from mouse RNA using the iScript reverse transcription kit (Bio-Rad) per the
manufacturer’s instructions, with 1mcg RNA per 20 mcl reaction. For non-quantitative RT-PCR, PCR
reactions were run with Platinum Taq PCR supermix (Invitrogen) for 30-40 cycles and run on a 2%
agarose/TAE gel.

For quantitative RT-PCR, reactions were prepared using iQ SYBER green Supermix (Bio-Rad)
according to the manufacturer’s instructions and were run on a MyQ single-color real-time PCR detection
system (Bio-Rad). PCR settings were the same for all primer sets: following a 5-minute denaturation step at
95 degrees, each PCR cycle consisted of 30 seconds denaturation at 95°C, 30 seconds annealing at 58°C,
and 30 seconds elongation at 72°C for 40 cycles. After cycling was complete, melting curves were
determined for the products of each sample at 0.5°C increments from 55-95°C. All primer sets were shown
to have high amplification efficiency (>90%) under experimental conditions, and produced a single melting
peak and a single product of the expected length on agarose gel electrophoresis. Primer sets which did not
meet these criteria were redesigned as needed. Primer pairs were verified for specificity by running each
pair under standard experimental conditions against 5 pM of cDNA plasmid containing each of the other
genes. The threshold was reached at 15-18 cycles for specific gene / primer combinations, while no
threshold was reached at 30 cycles for nonspecific combinations.

Two primer sets were used for each experimental run on a 96-well plate. For each primer set, 20 mcl
reactions were set up in triplicate for each of nine tissues, with each reaction containing 1/20th of the
product of one RT reaction. One control well was included for each cDNA/primer set combination,
containing the product of a mock RT reaction in which reverse transcriptase was omitted. Also included on
the same plate were duplicate sets of five 10x dilutions of testes or (for Dcun1d2) heart cDNA prepared at a
higher concentration than the cDNA used in the experimental wells, such that all experimental data fell
within the standard curve. Fluorescence threshold level and data analysis mode were predetermined and
uniform for all runs.
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Analysis of quantitative RT-PCR data was performed via an adaptation of the method of Pfaffl,(109) in
which the efficiency of the PCR reaction was calculated using the dilution curves on each experimental
plate. The primer-pair specific efficiency was then used to calculate the fold-difference in expression
(averaged across three replicates) for each tissue relative to brain, using the experimentally obtained Ct
values. The values for each tissue were then normalized to the relative fold-difference in expression of 18s
ribosomal RNA. During pilot experiments, GAPDH and HPRT were also evaluated as normalization genes
and were found to produce equivalent results. Error bars reflect the range of expression calculated using the
average Ct for that gene plus or minus the root-mean-square of the variances for the three replicates.

Germ cell elutriation

Elutriation of mouse and rat germ cells was performed according to previously published
protocols(110-112) Briefly, testes were removed from normal Sprague-Dawley rats, minced and
trypsinized with 1 mg/ml trypsin and 19 Fg/ml DNase in phosphate buffered saline containing 0.1%
glucose, 0.06% lactate, and 1 mM pyruvate at 32°C for 30 min. The suspension was filtered through
300~km and 80-pm nylon mesh membranes, and then through glass wool. The suspension was centrifuged
and the pellets were resuspended in 100 ml of PBS with 250 Fg/ml DNase, 0.02% soybean trypsin
inhibitor, and 5 mM naphthol disulfonic acid. The cells were cooled, filtered through a 25pm nylon mesh
membrane, and loaded into a JE-6B elutriation rotor. Spermatogonia, mid-late pachytene spermatocyte,
round spermatid, elongating spermatid, and late spermatid-enriched fractions were collected according to a
validated elutriation sequence and were checked morphologically for purity. RNA was extracted from
purified cell populations using standard techniques.

Quantitative RT-PCR for these samples was performed with the previously described primer sets,
using a PE Applied Biosystems model 7700 Sequence Detection System. Expression relative to whole
testes was calculated by the standard curve method, and normalized relative to 18s ribosomal RNA.
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Contributions of co-authors and other collaborators

Except as stated below, all experiments presented in the “Results” section were planned and executed
by R. Ryan. As principal investigator of the Laboratory of Epithelial Cancer Biology, B. Singh provided
guidance and approved all experiments. Senior Research Scientist Y. Ramanathan assisted in the planning
of all experiments. Gel filtration and HeLa-S elutriation experiments were conducted by R. Ryan in the
laboratory of Andrew Koff, who generously provided his equipment, time, and expertise. L. Choi assisted
with the cloning of eGFP fusion constructs and with fluorescent microscopy. Y. Yonekawa performed GST
pulldown experiments, using fusion constructs created by R. Ryan. In-vitro neddylation reactions were
performed by R. Ryan, and were adapted from assays optimized by A. Kim and Y. Yonekawa, who also
assisted in preparation of materials. Mouse tissues for RNA extraction were harvested by A. Kaufman, who
also provided helpful insights regarding his Dcun1d1-/- mouse work. Mouse germ cell elutriation was
performed by Lyann Mitchell in the laboratory of P. Morris, who contributed her equipment, time and
expertise. RNA extraction and quantitative RT-PCR for germ cell elutriation experiments were performed
and analyzed by K. Hwang, using primers sets designed by R. Ryan. All other quantitative RT-PCR
experiments were performed by R. Ryan. The full text of this manuscript was written by R. Ryan, in
consultation with the co-authors.
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Results

A.

Gel filtration analysis of SCCRO and CDL complexes

Our group has previously demonstrated that SCCRO participates in protein-protein interactions with
several cullin proteins, as well as with ROC1 and CAND1, which are well-established as members of
cullin-containing complexes. Interactions with cullin proteins have been independently reported for
SCCRO orthologs in S. cerevisiae and C. elegans. The observation that SCCRO interacts with CAND1 but
not with SKP1(21) suggested that SCCRO may directly interact with the inhibitory CAND1-cullin-ROC1
complex, but not with active E3’s such as the SKP1-CUL1-F-box (SCF) complex. We had also
demonstrated an interaction between SCCRO and the E2 for neddylation, UBC12. There has been no
previous evidence as to whether SCCRO’s interactions with cullin-containing complexes, or with UBC12,
are transient, or if in fact it forms stable complexes with any of its known interactors.

To approach this question, we performed size exclusion chromatography on lysates prepared from
several human cell lines, including an immortalized human keratinocyte line (HaCaT), and the epithelial
tumor lines HeLa and SCC15. We then used western blot analysis to determine the apparent molecular
weight of complexes containing SCCRO and SCCRO-associated proteins, based on a previously
determined standard curve (Figure 1). Similar data was obtained for all three cell lines.

Western blot analysis demonstrated similar distributions for CUL1 and ROC1, which co-migrated in a
broad range of fractions corresponding to complexes from 115 to greater than 1000 kD in size (Figure 1).
This is consistent with the known, stable association of ROC1 in a range of active and inactive cullincontaining complexes. A small amount of ROC1 immunoreactivity was also noted in fractions with an
apparent molecular mass of 9-12 kD, consistent with the size of monomeric ROC1 (13kD). CAND1 comigrated with CUL1 and ROC1 in a subset of fractions representing complexes between 115 and 575 kD.
These findings are consistent with the presence of a stable CAND1-CUL1-ROC1 complex.
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Figure 1: Gel filtration analysis followed by western blot for SCCRO and associated proteins. Arrows
indicate fractions in which monomeric (non-complexed) forms of each protein would be predicted to
appear, based on MW and a previously determined standard curve. The actual migration of monomeric
SCCRO at an apparent MW of 32 kD was separately confirmed using purified protein (*). Note similarity
in distribution of complexes containing CUL1 and ROC1.
We next looked at the distribution of UBC12, the E2 for cullin neddylation, which is known to
transiently interact with cullin-containing complexes. UBC12 immunoreactivity was noted in two separate,
distinct peaks, with one peak corresponding to an Mr of 27 kD (close to the actual molecular weight of
monomeric UBC12, 21 kD), and a second peak within the upper range of CUL1 containing complexes.

Peak SCCRO immunoreactivity was not found in fractions containing significant amounts of CAND1,
CUL1, or ROC1. SCCRO was present in a broad range of fractions, with a peak at an apparent molecular
weight of 72 kD and an extended “tail” of immunoreactivity into fractions representing Mr >200 kD. This
contrasts with the migration pattern of purified, bacterially expressed SCCRO, which migrated at an Mr of
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32 kD (consistent with the true MW of monomeric SCCRO, 30 kD). The migration of lysate-derived
SCCRO at a higher molecular weight than that of purified SCCRO is likely due to interactions with other
proteins, which were not specifically identified in this experiment. We concluded that the majority of
endogenous cellular SCCRO is not stably associated with CAND1 or cullin-containing complexes, nor with
UBC12. It is likely that SCCRO interactions with those complexes are either transient or involve only a
small fraction of endogenous SCCRO molecules.

B.

Expression of SCCRO across the cell cycle

S. cerevisiae dcn1p has been shown to affect the neddylation state and function of the Cul1 homolog
cdc53p.(106) One of the best-established roles for Cul1-containing SCF complexes is in control of the cell
cycle. While cellular levels of Cul1 protein are constant across the cell cycle, other factors involved in SCF
function, such as the ubiquitin E2 enzymes Ubc10 and Ubc7, do vary at specific stages.(113) These
variations allow for increased SCF-dependant ubiquitination activity towards specific targets, such as
cyclins or cdk inhibitors, at appropriate transition points in the cycle. We reasoned that SCCRO expression
might also be differentially regulated throughout the cell cycle, and that such a pattern of expression might
provide clues to SCCRO’s normal function.

We first evaluated the expression of SCCRO protein in three well-characterized human suspension
culture cell lines, HeLa-S, HeLa-S3, MANCA, and TK-6, and found them to be equivalent (data not
shown). We chose to continue our analysis in the HeLa-S cells. Elutriation is a method of fractionating
cells according to cell volume, with smaller cells appearing in earlier fractions, and larger cells in later
fractions. Because suspension culture cells increase in size continuously throughout the cell cycle, the first
fractions should contain post-mitotic, early G1 cells, while successive fractions should be enriched for later
cell-cycle stages. We collected a total of 10 separate elutriated fractions from a single log-phase culture of
HeLa-S cells. Small aliquots of each fraction were frozen for FACS analysis of nuclear DNA content,
while a cell lysate was prepared from the bulk of the cells in each fraction.
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Figure 2: (a) FACS analysis of nuclear DNA content showing cell-cycle stage distribution of elutriated HeLa-S
fractions. (b) Western Blot analysis of lysate from elutriated cell fractions shows expected cell-cycle specific
expression of cyclin A and p21, but no variation in levels of CAND1, Cul1, high molecular weight (neddylated) cul1,
or SCCRO. (c) Western blot following gel filtration of elutriated HeLa fractions. The three lanes above and below each
number represent equivalent gel filtration fractions from three separate runs, each with a different elutriated cell lysate
input. For each trio, the first lane represents lysate from elutriated fraction F3 (G1-enriched), the second F6 (Senriched), and the third F8 (G2-enriched).

Cell cycle analysis based on DNA content revealed that unfractionated cells were approximately 61%
G1 (1n), 23% S (1n < x < 2n), and 15% G2 (2n). DNA content analysis of each fraction revealed that
fractions 2-8 represented enrichment of successively later phases of the cell cycle, with fractions 2 and 3
representing essentially 100% G1 cells, while fraction 6 contained 41% G1, 43% S, and 13% G2 cells, and
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fraction 8 contained 26% G1, 29% S, and 42% G2 (Figure 2a). Pure fractions representing cells in later
stages of the cell cycle were not achieved, likely due to co-elutriation of clumps of small G1 cells along with
the larger, late-phase cells. However, the enrichments achieved were sufficient to detect significant
variations in protein expression across the cell cycle, as demonstrated in the next phase of the experiment.

To further validate the cell-cycle enrichment of our fractions, we used western blot to analyze the
expression of two proteins whose levels are known to vary across the cell cycle. Cyclin A is essentially
absent during G1, but is increasingly expressed in S and G2 phases(114). p21CIP1 is a cyclin-dependant
kinase inhibitor whose cellular levels rise during G1, fall precipitously at the G1-S transition, remain low
throughout S, then rise again moderately in G2(115). As expected, western blot analysis of elutriated HeLaS fractions showed that Cyclin A was absent from pure G1 fractions, but was increasingly expressed in S
and G2 – enriched fractions (Figure 2b). Also as expected, p21CIP1 revealed a strong expression peak in
fractions 3-5 (late G1), with low levels detected in later fractions. In contrast to the clear variations seen in
the levels of these known cell-cycle regulated proteins across our fractions, we could detect no significant
differences in the expression of CAND1, CUL1, high molecular weight (neddylated) CUL1, or SCCRO.

While overall levels of SCCRO did not vary across the cell cycle in HeLa-S, it remained possible that
the levels or binding properties of unknown SCCRO-interacting proteins might vary, resulting in
differences in the size of SCCRO-containing complexes across the cell cycle. We tested this possibility by
performing size exclusion chromatography on lysate from elutriated HeLa-S cell fractions 3, 6, and 8, and
evaluating the apparent molecular weight of SCCRO and CUL3 complexes by western blot (Figure 2c).
There was no difference between the three cell fractions in the Mr of complexes containing SCCRO or
CUL3.

C.

Genomic / Bioinformatic / Phylogenetic analysis of SCCRO and Dcn1d genes

Analysis of Genbank genomic and transcript databases revealed a variety of vertebrate genes with
coding sequence homology to SCCRO and dcn-1 (hereafter referred to as defective in cullin neddylation –
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1 – like domain – containing, or “Dcun1d” genes). While transcripts of the murine ortholog of SCCRO
have been described, there has been no published characterization of any paralogous Dcun1d genes or gene
products.1

Human
Sequence

Entrez
Gene name

Unigene
Identifier

Genomic
Locus

ORF
Predicted protein
length (bp)
product (kD)

Mouse
Ortholog

DCUN1D1
/SCCRO (gene)

DCUN1D1

Hs.104613

3q26.3

777

30.0

Dcun1d1/
Mm.379305

DCUN1D2
(gene)

DCUN1D2

Hs.369453

13q34

777

21.3

Dcun1d2/
Mm.368890

DCUN1D3
(gene)

DCUN1D3

Hs.101007

16p12.3

912

34.3

Dcun1d3/
Mm.31539

DCUN1D4
(gene)

DCUN1D4

Hs.605388

4q11

876

34.1

Dcun1d4/
Mm.220312

DCUN1D5
(gene)

DCUN1D5

Hs.503716

11q22.3

711

27.4

Dcun1d5/
Mm.27293

RP42Ψ
(pseudogene)

LOC153893

N/A

6q16.3

N/A

N/A

N/A

Dcun1d-like
fragment

N/A

N/A

9p24

N/A

N/A

N/A

Table 1: Genes, pseudogenes, and other sequences in the human genome with coding homology to Dcn1
We used Genomic BLAST to search the human genome for all DNA sequences with coding homology
to SCCRO. We identified sequences at seven unique loci in the human genome, including the known
SCCRO gene at 3q26.3 (Table 1). A sequence at 6q16, previously reported as the locus of a human “RP42
homolog,”(19) proved in fact to be an intronless pseudogene that lacks a significant open reading frame.
Another non-coding sequence homologous to SCCRO was found at 9p24. The remaining four loci were
each predicted to represent a true protein-coding gene containing a dcn-1-like domain. These genes had not
been previously characterized, and at the time of our initial analysis lacked consistent annotation in NCBI
databases. We verified these findings by performing translated BLAST of SCCRO against real and
predicted human expressed sequences, and recovered a corresponding set of transcripts for all five genes.

1

For a thorough discussion of how gene orthology and paralogy are determined, see (116)
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Using a similar methodology, we identified highly conserved orthologs to each of the five human
DCUN1D genes in Mus musculus and Danio rerio. All five identified genes share common properties of
protein-coding genes, including multiple exons, strong predicted translation initiation (Kozak) sequences,
and significant (>700 bp) open reading frames. Since our original analysis, these genes have been
independently assigned a uniform NCBI nomenclature: DCUN1D1, DCUN1D2, DCUN1D3, DCUN1D4,
and DCUN1D5, which will be used throughout the remainder of this manuscript.

Because Genbank expressed sequences suggested the existence of alternate spliceforms for human
DCUN1D2 and DCUN1D4, as well as for their mouse orthologs, we wanted to confirm that full-length
coding sequence transcripts were expressed before further analysis. Due to our ongoing work with
transgenic mouse models of Dcun1d1 overexpression and deletion, as well as the comprehensive
availability of murine cDNA’s, we chose to perform our characterization of the vertebrate Dcun1d genes in
the mouse. We designed RT-PCR primers to amplify the coding sequences of murine Dcun1d1, Dcun1d2,
Dcun1d4, and Dcun1d5 (the coding sequence of Dcun1d3 is contained in only two exons, which are
present in all Dcun1d3 mRNA sequences in Genbank). We extracted RNA from murine testes, lung, and
heart, and performed RT-PCR with the appropriate primer sets. Products of the expected length were the
dominant species produced for all four genes – three faint, lower MW bands were produced for Dcun1d2 in
heart RNA, suggesting that truncated spliceforms are expressed in that tissue, but at a much lower level
than the full-length CDS transcript (data not shown). No PCR products suggestive of alternately spliced
transcripts were seen in mouse for Dcun1d4.

We next used Genbank expressed sequences and data from completed genome projects to perform a
phylogenic analysis of the five paralogous Dcun1d genes. All five genes appear to be conserved among
vertebrates for which sufficient genomic or transcriptomic information is available. The amino acid
sequences of DCUN1D1 and DCUN1D2 in mice are identical in length and show 80% sequence identity to
one another, suggesting that these proteins serve very similar or identical molecular functions. They appear
to have resulted from a gene duplication event early in the deuterostome / chordate lineage, since they are
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both present in Danio rerio, but are co-orthologous to a single gene, “dcun1d1l,” found in the invertebrates
Drosophila melanogaster and Anopheles gambiae. A similar pattern is seen for Dcun1d4 and Dcun1d5,
which share co-orthology to a single insect gene, “dcun1d4l.” Dcun1d3 is well conserved in the purple sea
urchin Strongyloides purpuratus, and is more divergent but recognizable as an ortholog in Drosophila and
Anopheles. Thus, the five vertebrate genes can be sub-classified into three orthologous groups which are
conserved in diverse metazoan clades. While all these genes show strong conservation of the central and Cterminal sequences (the Dcn1-like domain), each of the orthologous groups possesses a unique and
characteristic N-terminal motif (Figure 3, 4a).

Proteins of the first group, the orthologs of Dcun1d1 and Dcun1d2, possess an N-terminal domain with
strong homology to the UBA-like domain found in S. cerevisiae Dcn1 and C. elegans Dcn-1.(103) In fact, a
BLAST search for similar expressed sequences in the “taxonomically broad EST database”
(TBestDB)(117) reveals that “UBA-Dcun1d” orthologs are conserved in species from five of the six
phylogenic “supergroups” currently proposed to encompass most or all of eukaryotic diversity, including
Opisthokonta, Plantae (Arabidopsis), Amoebozoa (Dictyostelium), Chromalveolata (Tetrahymena), and
Excavata (Reclinomonas, Malawimonas) strongly suggesting that a UBA-Dcun1d gene was present in the
last eukaryotic common ancestor. This underscores the importance of Dcun1d proteins in a fundamental
process of eukaryotic cells.

Proteins of the second class are represented by Dcun1d4 and Dcun1d5 in vertebrates. Their Nterminals contain a conserved motif consisting of proline followed one or two residues later by 4-5 basic
amino acids, a sequence similar to the canonical nuclear localization signal (NLS). We henceforth refer to
this class of predicted Dcun1d proteins as the “NLS-Dcun1d” proteins. The nucleotide sequence coding for
the NLS-like motif of both Dcun1d4 and Dcun1d5 is preceded by an AUG codon. However, Dcun1d4
proteins are predicted to have an extended N-terminal prior to the NLS-like sequence, due to a conserved
upstream translation initiation sequence which is not shared with Dcun1d5. The murine Dcun1d5 protein
sequence is 65% identical to the corresponding sequence in the Dcun1d4 protein. We found no evidence for
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NLS-Dcun1d genes in non-metazoans, suggesting that the first NLS-Dcun1d gene may have evolved early
in animal evolution.

The third orthologous group consists of the single gene Dcun1d3, which appears in the genomes of
most fully sequenced metazoans, although like the NLS-Dcun1d genes, Dcun1d3 is not present in C.
elegans. Dcun1d3 has a slightly more divergent dcn1-like domains compared to the other classes, and is
distinguished by a long N-terminal domain consisting of a predicted non-ordered secondary structure
(NORS) domain, and a potential N-myristoylation sequence at the N-terminal. The sequences of Homo,
Mus, Tetraodon, and Strongylocentrotus Dcun1d3 proteins classify as “reliable” substrates for Nmyristoyltransferase according to the “MYR predictor” web server. These findings suggest that the nonordered N-terminal portion of the Dcun1d3 protein might function as a flexible tether, linking the protein to
a plasma or organelle membrane via a fatty acid anchor. We tentatively refer to this orthologous group as
the “MYR-Dcun1d” genes. However, it should be noted that the divergent N-terminal of insect Dcun1d3like proteins are not predicted to be likely N-myristoylation substrates by the MYR algorithm.

D.

Cloning and expression of murine Dcun1d genes

The 5’ untranslated regions of transcripts for all five genes are well-represented by expressed
sequences in Genbank, and translation initiation sites can be predicted for all five genes, based on the lack
of upstream AUG codons and conservation between organisms. While initiation sequences for the five
paralogs display varying degrees of homology to the Kozak consensus sequence, all five possess an
adenine at the -3 position, which is known to be the most important upstream determinant of an efficient
initiation sequence.(118)

We obtained full-length, sequence-verified cDNA clones for each of the five murine dcun1d genes
from the RIKEN consortium. The five paralogs were cloned into the mammalian expression vector
phCMV3 to produce c-terminal HA-tagged coding sequences, preceded by the endogenous initiation
sequence to the -9 position. Expression of these plasmids in HeLa cells produced proteins of the expected
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molecular weight on HA western blot (Figure 4b).

Interestingly, we were unable to produce strong expression of Dcun1d4 protein using the phCMV3
vector. This was true even after replacing the predicted endogenous initiation sequence with the Kozak
consensus sequence. We also found that expression of Dcun1d4 in bacteria via an N-terminal GST-fusion
vector (pGex3T4) resulted in very weak expression compared to similar constructs for the other four genes
under a variety of conditions. Thus, low expression of the Dcun1d4 protein is independent of promoter,
initiation sequence or translation in a eukaryotic or prokaryotic system. A likely explanation for this is that
translation is inhibited by the secondary structure of the Dcun1d4 mRNA sequence which was predicted to
code for a unique N-terminal not shared with Dcun1d5.

It is possible that endogenous Dcun1d4 transcripts might be translated from the downstream AUG that
corresponds to the initiation site of Dcun1d5, thus producing a shorter protein with full-length homology to
Dcun1d5 and Drosophila Dcun1d4L. However, this would require an unusual 5’UTR regulatory
mechanism to prevent the ribosome from initiating translation on what appears to be a favorable, in-frame
upstream site. It is interesting to note that of the eight vertebrate species for which Dcun1d4 transcript or
genomic sequences are available, the upstream AUG start codon, though conserved, is shifted out of frame
with the downstream coding sequence in two species (Bos taurus and Canis familiaris). The downstream
AUG is conserved in all eight species. A definitive answer to this question could only be produced through
the purification and sequencing of endogenous Dcun1d4 proteins, which was not attempted in this study.

We cannot completely exclude the possibility that the transgenically expressed Dcun1d4 protein is
more rapidly degraded in both bacteria and eukaryotic cells than are the other Dcun1d proteins. However it
is unlikely that the surviving Dcun1d4 protein is misfolded, given the similarities in subcellular
localization, protein-protein interactions, and in-vitro functional activity seen between Dcun1d4 and
Dcun1d5 in subsequent experiments.
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Figure 3: Multi-alignment of vertebrate Dcun1d proteins and orthologs in other organisms. Sequences are
grouped by orthologous group, with proteins containing the UBA domain (green underline) at top, basic
nuclear localization signal (red underline) in the middle, and N-myristoylation signal (purple underline) at
bottom (note poor conservation of the MYR domain in Drosophila Dcun1d3L). The yellow underline
marks the region of the predicted vertebrate Dcun1d4 protein which may not be endogenously translated
(see further discussion in text).
All Dcun1d proteins show conservation of the Dcn-1-like domain (orange overline), which includes the
more strongly conserved PFAM DUF298 domain (blue overline). The black arrowhead marks the
universally conserved aspartate 241 (numbered with reference to Homo Dcun1d1) which is required for
cullin binding and lies in the most strictly conserved region of the Dcn1-like domain.
Species names are abbreviated as follows: Hs = Homo sapiens, Dr = Danio rerio, Tn = Tetraodon
nigroviridis, Sp = Strongylocentrus purpuratus, Dm = Drosophila melanogaster, Ce = Caenorhabditis
elegans, Sc = Saccharomyces cerevisiae, Dd = Dictyostelium discoideum, At = Arabidopsis thaliana.
Genbank ID’s for all sequences are listed in Appendix B.
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E.

Subcellular localization of Dcun1d proteins is dependant on N-terminal functional domains
As an initial approach to distinguishing the function of mammalian Dcun1d genes, we decided to test

the function of predicted N-terminal localization motifs by comparing the localization of N-and C-terminal
eGFP-tagged SCCRO (human DCUN1D1) protein to equivalent fusion proteins containing murine
Dcun1d2, Dcun1d3, Dcun1d4, and Dcun1d5 (Figure 4c).

The localization of N- and C- terminal tagged SCCRO and Dcun1d2 is diffusely nuclear and
cytoplasmic, with slightly more intense fluorescence in the nucleus compared to EGFP alone. No
significant localization heterogeneity was seen between interphase cells in asynchronous cultures,
suggesting that there is no cell-cycle specific localization of these proteins.

c.
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Figure 4: a. Schematic representation of domains in the five conserved vertebrate Dcun1d proteins. b. Western blot
showing transgenic expression of C-terminal HA-tagged murine Dcun1d proteins in HeLa cells. c. Localization of cterminal eGFP tagged SCCRO and murine Dcun1d proteins in transfected HeLa cells. D1 = SCCRO, D2 = Dcun1d2,
D3 = Dcun1d3, D3(G2A) = Dcun1d3(G2A), D4 = Dcun1d4, D5 = Dcun1d5.
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In contrast to the UBA-Dcun1d proteins, the murine NLS-Dcun1d proteins, Dcun1d4 and Dcun1d5,
localized almost exclusively to the nucleus, suggesting that the basic N-terminal sequence does indeed
function as a nuclear localization signal.

The C-terminal tagged Dcun1d3 protein shows a strikingly different localization pattern from the other
four paralogs, with florescence seen outlining the plasma membrane as well as peri-nuclear organelles.
Fluorescence was notably absent from the nucleus. Interestingly, the N-terminal tagged fusion protein (not
shown) had a diffuse localization pattern throughout the cell. This would be expected if membrane
localization of Dcun1d3 were dependent on N-myristoylation, a modification which can only occur at a
sequence located on a free N-terminal. This was further confirmed by loss of membrane localization in a Cterminal GFP-tagged Dcun1d3(G2A) mutant, since N-terminal fatty acid conjugation can only occur on a
glycine residue (the methionine in position 1 is cleaved from N-lipidated proteins).

F.

In-vitro interaction of bacterially expressed Dcun1d proteins and CDL components.

The high degree of homology between the dcn-1-like domains of the five mammalian Dcun1d proteins
suggests that they likely carry out similar molecular functions. We tested the in vitro protein binding

α−CAND1
α−CUL1
α−CUL2
α−CUL3
α−ROC1
GST
only

GSTSCCRO

GSTGSTGSTGSTDCUN1D2 DCUN1D3 DCUN1D4 DCUN1D5

Lysate
(1/10 input)

Figure 5. All five mouse Dcun1d genes interact with CAND1, cullins, and ROC1, as measured by
pulldown of bacterially expressed GST-Dcun1d fusion proteins in HeLa lysate. 1/10 the original volume of
lysate was run in the right-hand lane for comparison.
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properties of the five murine Dcun1d genes in a GST pulldown assay, and confirmed that all five paralogs
showed specific interactions with CUL1, CUL2, CUL3, CAND1, and ROC1 (Figure 5). The similar
binding properties of the paralogs are not surprising, given the high degree of conservation of the Dcn-1like domain.
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Figure 6. Dose-dependant effects of bacterially expressed SCCRO or murine Dcun1d proteins in three
separate sets of 10-minute in-vitro neddylation reactions. Products of the same reactions were used for all
blots within each section. a. Significantly increased CUL3 neddylation is seen with addition of SCCRO and
Dcun1d5, but not with Dcun1d3. b. SCCRO, Dcun1d4, and Dcun1d5 increase neddylation of CUL3 in a
dose-dependant manner. c. SCCRO, Dcun1d2, and Dcun1d5 increase neddylation of CUL3 in a dosedependant manner. Note the lack of a significant effect on CUL1 neddylation in a, b, and c, and the modest
but consistent enhancement of CUL2 neddylation in b.

47

G.

Specific enhancement of in vitro cullin neddylation by bacterially expressed DCUN1D proteins

To test the functional properties of Dcn-1 domain-containing proteins, we have established an in-vitro
assay for the neddylation of cullins in mammalian cell lysate. In previous experiments, addition of
bacterially expressed SCCRO protein, but not SCCRO(D241A), which loses binding affinity for cullins,
significantly enhanced the neddylation of cullin 3 in a dose-dependant manner.(21)

Under similar conditions, we found that SCCRO and murine Dcun1d2, Dcun1d4, and Dcun1d5 all
enhance neddylation of CUL3 in a dose-dependant manner (Figure 6a, 6b, 6c). Enhancement of CUL2
neddylation by these four proteins was far more modest (Figure 6b), and little or no enhancement of CUL1
neddylation was observed (Figure 6a, 6b, 6c). This suggests that the neddylation-enhancing effects of
Dcun1d proteins may be selective within the cullin family. Interestingly, we observed no significant
enhancement of cullin neddylation with any amount of added Dcun1d3 (Figure 6a).
H.

Tissue-specific expression of Dcun1d genes in the mouse

One of the more puzzling features of our initial work on murine Dcun1d1 was the limited phenotypic
abnormalities of the Dcun1d1-/- mouse. The existence of a second conserved protein in vertebrates,
Dcun1d2, with nearly identical structural and functional properties to Dcun1d1, suggested that the two
corresponding genes might be distinguished primarily by their patterns of expression. In other words,
Dcun1d1 and Dcun1d2 may perform the same cellular function, but in different tissues or stages in
development. According to this hypothesis, we would only expect to see consistent defects in the Dcun1d1/-

mouse in tissues where Dcun1d2 shows little or no expression. Given the similar functional properties of

their protein products in vitro, Dcun1d4 and Dcun1d5 could potentially compensate for loss of Dcun1d1
expression as well. However, the distinct pattern of sub-cellular localization and absence of the UBA
domain in the NLS-Dcun1d proteins suggests that they are not likely to replicate all the functions of
Dcun1d1 in vivo. To test these hypotheses, we decided to further investigate patterns of Dcun1d gene
expression in the mouse.
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While previous authors have reported the expression of murine Dcun1d1 by northern blot,(18, 19) this
work was done with probes complementary to the coding sequence of Dcun1d1, which contains regions
nearly identical to the corresponding sequences in Dcun1d2. This raised the possibility that crosshybridization to Dcun1d2 transcripts could have confounded the earlier data. To rule this out, we performed
northern blot using a short, PCR-generated probe against a 100 BP region of murine Dcun1d1 (diagrammed
in Figure 7) which shares no homology with Dcun1D2. Our results confirmed the previously reported
pattern of two long (~3.5 and 4.0 kD), ubiquitously expressed Dcun1d1 transcripts as well as several
shorter, highly expressed, testis–specific transcripts (Figure 8a).
D1 Northern blot probe

Dcun1d1
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D1ex1

D1RT3

D1ex1

D1RT3

D1RT2
AAAAA

AAAAA
D1ex1ab
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transcripts

AAAAA
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AAAAA
D2RT1

Dcun1d3
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D3RT1

Dcun1d4
AAAAA
D4RT2

Dcun1d5
AAAAA
D5RT1

Figure 7: Diagram of murine Dcun1d gene transcripts showing the location of PCR products amplified for
quantitative real-time RT-PCR.
Pourcel et al. cloned several of the testis-specific short transcripts of Dcun1d1 and showed that they
appear to be produced through the use of alternate polyadenylation sites, which result in truncation of the
3’UTR. While some of the testis-specific transcripts sequenced by Pourcel et al. contained the usual first
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exon, others contained alternate 5’ sequences, which they speculated were produced through transcription
of the Dcun1d1 gene from an unidentified alternate promoter, followed by the splicing of several new
upstream exons, dubbed 1a, 1b, and 1c. Our examination of public genome project data revealed a
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Figure 8. (a) Northern blot analysis of Dcun1d1 transcripts using a short probe lacking homology to other Dcn1domain containing genes. Note expression of long Dcun1d1 transcripts in many tissues, while short transcripts are
restricted to the testes. (b) qRT-PCR expression analysis of Dcun1d1 and Dcun1d2. The second Dcun1d1 graph omits
data from the testes to highlight differences in expression of other genes, but the data otherwise identical. Tissuespecific expression was normalized to 18s rRNA. Error bars show +/- SEM of fold-difference for three replicate wells.
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continuous sequence exactly matching the sequence of all three alternate “exons” 6.5 kb upstream of the
transcriptional start site for the ubiquitous transcript. Thus, this sequence actually seems to represent a
single alternate first exon (renamed “exon 1abc”), which is expressed from a second upstream promoter
and contains two alternate donor sites for splicing to the ubiquitous exon 2.

A comparison of the Dcun1d1 exon 1abc sequence to genomic sequences from human, rat, cow, and
dog shows that only the shorter of the two spliceforms (containing the “exon1ab” sequence) seems to be
phylogenically conserved. All Genbank EST’s containing the alternate first exon were cloned from testis or
testis-derived cells, supporting the idea that these transcripts are testis-specific.

To further examine the relative expression of Dcun1d1 transcripts in murine testes and other tissues,
we designed sets of quantitative RT-PCR primer pairs to detect features of specific Dcun1d1 transcripts,
including those containing the ubiquitous first exon (D1ex1), or exons 1ab or 1abc (D1ex1ab and
D1ex1abc respectively). We designed a primer set to amplify a region of the Dcun1d1 3’ UTR present in
the ubiquitously expressed transcripts, but absent from the short, testes-specific transcripts (D1RT2). We
also designed a primer pair specific for the full-length Dcun1d2 transcript, taking care to minimize
homology with Dcun1d1.

The primer pair D1RT3, which amplifies a region common to all known Dcun1d1 transcripts, showed
a multi-tissue expression profile consistent with our northern blot findings, with moderately increased
expression in brain, heart, and kidney relative to liver, lung and spleen, and approximately 50-fold higher
expression in the testes than in all other tissues (Figure 8b). However, expression of the long-transcript
specific primer pair D1RT2 was similar in testes and other tissues (data not shown), consistent with the
northern blot finding that only short Dcun1d1 transcripts are highly expressed in testes. In contrast,
Dcun1d2 showed significantly higher expression in brain, heart, and skeletal muscle than in testis and other
tissues (Figure 8b). Primer pairs specific for Dcun1d1 transcripts containing exon 1ab or exon 1abc
produced little or no signal in tissues other than the testes (data not shown).
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Figure 9: Expression of murine Dcun1d genes by RT-PCR. All three are strongly overexpressed in testis. The testis
data is omitted in right-hand charts to highlight variation in expression between other tissues. Tissue-specific
expression was normalized to 18s rRNA. Error bars show +/- SEM of fold-difference for three replicate wells.

Quantitative RT-PCR was also used to compare the expression of Dcun1d3, Dcun1d4, and Dcun1d5
across nine mouse tissues (Figure 9). All three genes had their highest expression in the testis, though the
difference was not as dramatic as with Dcun1d1. Dcun1d4 and Dcun1d5 otherwise showed patterns of
expression which were quite distinct from one another, which may explain their conservation as separate
genes, given their similar sub-cellular localization and functional properties.
I.

Germ cell elutriation
The confirmation of high Dcun1d1 expression in the testes, in light of the male sterility phenotype of

the Dcun1d1-/- mouse, strongly suggests that Dcun1d1 plays a specific role in spermatogenesis. To further
explore this, we took advantage of a robust elutriation method for the isolation of mouse germ cells in
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specific stages of spermatogenesis. We then isolated RNA from whole testis and enriched germ cell
fractions, and performed quantitative RT-PCR using the previously described primer sets (Figure 10).

a.

b.

Figure 10. (a) Overall expression of transcripts containing the Dcun1d1 coding sequence increase during
male germ cell maturation, as measured by the D1RT3 primer pair. In contrast, expression of long
transcripts of Dcun1d1 decrease during germ cell maturation, as measured by the primer set D1RT2,
located on the 3’ UTR of the long Dcun1d1 transcript. Dcun1d2 expression also decreases during
spermatogenesis. (b) Expression of alternate first exons of Dcun1d1 in elutriated mouse germ cells.
mT = whole mouse testes, Sg = spermatogonia, PS = pachytene spermatocytes, RS = round spermatids, ES
= elongating spermatids, LtS = late spermatids. Expression of each gene is quantified relative to expression
in whole testes. Error bars show SEM of fold-difference for three replicate wells.

Several interesting observations emerge from this data. First, levels of Dcun1d1 transcripts as a whole
(primer set D1RT3) are equal or higher in germ cells than in whole testis (recalling that whole testis
expression of Dcun1d1 is 50-100 fold higher than in other tissues), suggesting that germ cells specifically
up-regulate Dcun1d1. While Dcun1d1 transcripts as a whole increase during germ cell development, the
level of transcripts containing the 3’ UTR primer set D1RT2 show a steady decline, demonstrating that the
alternate polyadenylation mechanisms which produce short Dcun1d1 transcripts are up-regulated during
spermatogenesis. Thus, the “testes-specific” short Dcun1d1 transcripts noted on northern blot appear to be
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enriched in maturing germ cells. Conversely, levels of Dcun1D2, which are very low in whole testes
compared to brain and muscle tissue, decline even further in developing germ cells.

The patterns of expression of the three different first exons found in testis Dcun1d1 transcripts are
nearly identical across the stages of spermatogenesis. This argues that while the testes-specific alternate
promoter is specifically turned on in germ cells, activity of the ubiquitous promoter also increases, resulting
in a mix of the three alternate transcripts. There is evidence of developmentally precise regulation of the
Dcun1d1 gene across stages of spermatogenesis, with a sharp decrease in expression of all short Dcun1d1
transcripts seen in the pachytene spermatocyte stage, and again in elongating spermatids. Elutriation of
early germ cells in rats (not shown) also demonstrated distinct expression peaks in spermatogonia and
round spermatids.
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Discussion

Little is known about the significance and function of DCN-1-like proteins in vertebrates. To our
knowledge, our group is the first to provide any functional data about the protein products of these genes in
humans and mice, and four of the five genes characterized in this work have not been studied previously.

Core elements of the cullin-dependant ubiquitin ligase system are ancient in origin, and have been
strongly conserved over more than a billion years of divergent evolution between plants and metazoans.
Four of the five cullin classes (all but Cul5), Cand proteins, and the neddylation system are all present in
Arabidopsis. We have shown that DCN-1-like proteins are similarly ancient, and thus are likely to be
involved in basic processes common to most or all eukaryotic cells.

SCCRO expression levels are not a cell-cycle-specific influence on CRL activity

Because of the many cell-cycle specific proteins regulated by CRL complexes, and the importance of
these pathways in cancer, regulation of CRL complexes in specific stages of the cell cycle has been of great
interest in previous studies. Neither Cul-1 or Skp1, nor the interaction between the two, vary across stages
of the cell cycle in HeLa cells.(119) However, cell-cycle specific variations are seen in the levels of some
ubiquitin E2 enzymes as well as in Cul5, which is expressed in a cell-cycle dependant fashion in rat
adrenal endothelial cells.(120)

In contrast, we found no evidence for cell-cycle stage-specific variations in SCCRO or SCCRO
complex formation. Several caveats are necessary in interpreting these experiments. First, we have shown
that our polyclonal SCCRO antibody cross-reacts equally with other Dcun1d proteins, including murine
Dcun1d2, Dcun1d4, and Dcun1d5, so it is possible that variations in SCCRO expression might have been
masked by constant expression of another Dcun1d protein of similar molecular weight (i.e. Dcun1d2).
However, we have previously shown that RNAi constructs specific for SCCRO are capable of knocking
down >80% of anti-SCCRO immunoreactivity at 30 kD in many epithelial cell lines (including HeLa), so
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SCCRO is likely the major if not sole component of that band in HeLa-S. Second, HeLa-S cells are derived
from an epithelial malignancy, and it is possible that SCCRO levels are abnormally regulated in this cell
line. This is a reasonable concern, although expression of SCCRO in HeLa-S cells was not increased
relative to other human suspension cell lines we tested. If future studies suggest a cell-cycle regulatory role
for SCCRO, it might be useful to confirm these findings in cultured primary cells, or another nontransformed system.

Dcun1d genes diversified in metazoans to support cullin-related functions in specific subcellular
compartments

Analysis of model organisms with completely sequenced genomes reveals that a single ancestral
Dcun1d gene exists in plants, fungi, and many metazoans. This ancestral gene contains a UBA-like domain,
which was shown by our group and others to facilitate ubiquitin binding. As noted by Kurz et al., this
domain is lost in one of two isoforms of C. elegans DCN-1, and does not appear to be necessary for the
neddylation-enhancing function of Dcun1d proteins, since the UBA-lacking proteins Dcun1d4 and
Dcun1d5 enhance in-vitro neddylation reactions with roughly the same efficiently as the UBA-containing
Dcun1d1. There is little positive evidence to date regarding what the function of the Dcun1d UBA domain
might be.

The vertebrate Dcun1d4 and Dcun1d5 genes appear to have their origins in two gene duplication
events. The first of these, and the replacement of the new gene’s UBA domain with a basic nuclear
localization signal, must have occurred in a common ancestor of arthropods and chordates, since one gene
in this class is present in Drosophila. Because the murine UBA-Dcun1d genes are also present in the
nucleus, and because at least one of the NLS-Dcun1d genes (Dcun1d5) does not posses any other novel
domains in comparison to the ancestral Dcun1d genes, it is tempting to infer that these genes perform a
restricted subset of the functions performed by the UBA-Dcun1d genes – those which take place in the
nucleus and do not require certain UBA-mediated interactions. We did not create deletion mutants to
directly test whether the basic N-terminal motif of Dcun1d4 and Dcun1d5 was responsible for nuclear
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localization of these proteins. However, given its homology to known nuclear localization signals, and the
fact that it is the only conserved motif in Dcun1d4 and Dcun1d5 which is not present in the UBA-Dcun1d
genes, we believe this interpretation to be sound.

It will be important to know whether murine NLS-Dcun1d genes display the same transforming
properties as SCCRO, since a positive answer would focus our oncogenesis research on nuclear functions
of SCCRO, and could also prompt the investigation of a possible role for the NLS-DCUN1D genes in
human cancer. A negative answer would suggest that the oncogenic activity of SCCRO protein requires
cytoplasmic activity, nuclear-cytoplasmic shuttling, or the function of the UBA domain. Further
experiments with chimeric Dcun1d genes containing both the UBA and NLS domains, or containing a
nuclear export sequence, could help clarify these possibilities. Unfortunately, an initial attempt to test the
transforming potential of Dcun1d4 and Dcun1d5 in human epithelial cells was technically unsuccessful.

Our experiments with GFP-tagged Dcun1d3 and the MYR sequence mutant Dcun1d3(G2A) strongly
support the conclusion that this protein is membrane-bound via modification of its N-terminal, most likely
with a hydrophobic myristic acid anchor. It is unclear if this property is shared with all members of this
class, given the divergence of the Drosophila dcun1d3 gene, suggesting that Dcun1d3 orthologs may have
different functions in different metazoan phyla. We are also less confident that the function of murine
Dcun1d3 protein involves enhancement of cullin neddylation, since bacterially expressed Dcun1d3 did not
enhance our in-vitro neddylation reaction. However, the DCN-1-like domain of Dcun1d3 is relatively well
conserved, and this no doubt is responsible for its retained ability to bind CAND1 and cullins in GST
pulldown. A number of important ubiquitination pathways are known to operate at cellular membranes,
including ubiquitination of growth factor receptors on the plasma membrane, and ER quality-control
mechanisms which degrade misfolded proteins after translocation to the cytoplamic side of the ER
membrane, but to link any of these specific pathways to Dcun1d3 at this time would be speculative.

An important unresolved issue is whether or not Dcun1d3 binds to UBC12. Initial attempts to test this
question via GST-pulldown were technically unsuccessful. Failure of Dcun1d3 to bind UBC12 could
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explain its lack of neddylation activity, and could help in the identification of the UBC12 binding region in
SCCRO. Deletion analyses have suggested that the UBC12 binding site on SCCRO, like the cullin binding
site, is located in the C-terminal DUF298 domain. There are several residues in the highly conserved Cterminal domain which distinguish all Dcun1d3 proteins from SCCRO and other neddylation-competent
Dcn1d proteins. These include glycine 134, valine 138, and isoleucine 140 (numbers refer to the SCCRO
sequence), for which glutamate, serine, and phenylalanine are substituted in Dcun1d3 sequences. It would
be interesting to study the binding and functional properties of SCCRO proteins mutated at one or more of
these sites to contain the corresponding Dcun1d3 residues.

Our findings that the neddylation-enhancing activity of murine Dcun1d proteins is specific for CUL3
and, to a lesser extent CUL2, should be interpreted cautiously. As previously mentioned, in vitro studies of
the neddylation pathway have been useful for determining the basic molecular mechanisms of proteins in
this system, but do not fully capture the complexity of the system in vivo.

Tissue-specific expression patterns of Dcun1d genes are consistent with a role in neddylation

Despite the basic role that CRL’s and neddylation pathways seem to play in most eukaryotic cells,
there is significant evidence for specialization of function for many CRL’s and for DCN-1-like proteins, in
specific metazoan tissues and cell types. Expression levels of the six classic human cullins vary widely
across developmental stages and tissue types. CUL1, CUL2, and CUL3 are more highly expressed in 7-day
mouse embryos than in later stages, while the peak of CUL4b expression occurs at day 11. Relative to other
tissues, increased expression of CUL1 and CUL3, and to a lesser extent CUL2, CUL4a, and CUL4b, are
seen in the testes. CUL5 expression was not high in testes, but was elevated in heart and skeletal muscle,
which also contained relatively high expression of CUL1, CUL2, CUL3, and CUL4a. Brain represented a
peak in expression of CUL4b expression, while both CUL4a and CUL4b are high in spleen.

Patterns of Nedd8 expression are also highly variable across tissues and stages of development. Nedd8
expression is relatively high in early mouse embryos, peaking at about 11 days, before declining at later
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fetal ages. In human tissues, Nedd8 expression is highest in the heart and skeletal muscle, with moderate
expression in the brain. While Nedd8 itself shows only modestly increased expression in testes, the Nedd8
E1 and E2 enzymes have more pronounced expression peaks in that tissue, and are also high in skeletal
muscle, heart, and to a lesser extent, brain.(80, 121)

There are several interesting point to consider when comparing our expression data for the murine
Dcun1d genes to these previous findings. The first is that all tissues which highly express either Dcun1d1
or Dcun1d2 also show high expression of the neddylation pathway components, and conversely, neither
Dcun1d1 nor Dcun1d2 is highly expressed in a tissue which is low in Nedd8 or its E1 and E2 enzymes.
This further supports our hypothesis that the primary functions of Dcun1d1 and Dcun1d2 involve the
neddylation pathway. Furthermore, it suggests that certain tissues have a higher need for neddylation
activity than others, and that the diversification of Dcun1d genes in more complex metazoans may be
related to the need for more complex regulation of this system. Regarding the expression of the other three
Dcun1d genes, they were all relatively highly expressed in the testes, and Dcun1d4 was significantly higher
in brain than in other non-testes tissues. With the exception of our germ cell elutriation findings, most of
our data refers to gene expression at the level of tissues which contain a heterogeneous mix of cell types.
Expression of Dcn1d genes in specific cell types, such as hematopoetic cells or endothelial cells, will have
to be evaluated in future experiments.

Specific Dcun1d1 transcript expression patterns during spermatogenesis point to an expression leveldependant role

The concept that Dcun1d1 specifically facilitates an increased need for neddylation activity in the
testes is supported both by expression data and the phenotype of the Dcun1d1-/- mouse. In the present study,
we confirmed previous findings of short Dcun1d1 isoforms present only in testes, and extended those
findings by showing that these short transcripts are specifically upregulated in germ cells. While truncation
of the Dcun1d1 3’ UTR does not chance its coding sequence, it may play a role in maintaining the high
expression level of those transcripts in germ cells, since many mRNA’s have been shown to possess
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sequences in their 3’ UTR which enhance transcript degradation through interaction with RNA binding
proteins and microRNA’s (122). The existence of testes-specific transcript processing mechanisms is well
established, and the testis-specific poly-A polymerase (TPAP) is required for normal spermatogenesis.(123)

The testes-specific alternate promoter and first exon for Dcun1d1 likely play an important functional
role, given their phylogenic conservation. However, the protein product of this alternate transcript is hard to
predict, since the AUG initiation codon of the ubiquitous SCCRO transcript is replaced by a conserved
CUG encoded on exon 1ab. Exon 1ab does contain an upstream AUG in reasonable Kozak context, but it is
out of frame with the SCCRO protein sequence and lacks a coding sequence of significant length. An inframe AUG codon is present downstream in the Dcun1d1 coding sequence, but it is in very poor Kozak
context, and would also require ribosomal leakage over the upstream ATG or re-initiation for translation. A
more unusual, but intriguing possibility for translation of Dcun1d1 exon 1ab-containing transcripts would
be through the use of a non-canonical initiation codon, such as the previously mentioned conserved CUG.
Initiation of translation at non-AUG codons has been reported in mammalian germ cells for several
genes.(124-126) For example, CUG initiation codons are utilized for translation of several FGF-2 isoforms
in the testes of mice, rats and humans via a conserved internal ribosomal entry sequence (IRES) at the 5’
end of the transcript.(127, 128) Translation at the FGF-2 IRES seems to be activated in mouse germ cells in
response to rising testosterone levels in adulthood,(129), which correlates with the temporal pattern of
expression for short Dcun1d1 transcripts in mouse testes.(18)

Endogenous eukaryotic IRES sequences are poorly understood, and reliable prediction algorithms for
IRES sequences are currently lacking(130). It would be interesting to test the sequence of Dcun1d1 exon
1ab for IRES activity by cloning it into an appropriate bicistronic construct and expressing the construct in
germ cells. Previously we discussed evidence that the initial portion of the predicted Dcun1d4 coding
sequence is not efficiently translated. Since that gene is also most highly expressed in the testes, it might
also be fruitful to evaluate Dcun1d4 transcripts for the presence of an IRES or other non-canonical means
of translation.
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Our in-vitro studies provide evidence that two classes of DCN-1-like proteins show a neddylationenhancing activity which is relatively specific for CUL3, a result which is consistent with the original
identification of C. elegans dcn-1 through its effects on CUL-3–dependant degradation of the microtubule–
severing protein MEI-1. Our results suggest that the UBA-Dcun1d proteins may be significant regulators of
Cul3–dependent degradation pathways in mammals. The defects in embryogenesis observed in C. elegans
neddylation pathway mutants appear to occur because MEI-1 accumulates during a meiotic cycle which
occurs in the C. elegans embryo prior to the first mitotic division. The failure of a CUL-3 CRL to degrade
MEI-1 after meiosis is complete results in persistence of MEI-1 into mitosis, which interferes with
microtubule polymerization and proper formation of the mitotic spindle. It is therefore interesting to note
that spermatogenesis is also a process in which meiosis is followed by a complex, microtubule-dependent
event - the assembly of the flagellum and other structures of the mature sperm. The few sperm produced by
Dcun1d1-/- mice show gross morphological abnormalities, suggesting that disregulation of spermatid
structural proteins results from the absence of Dcun1d1.

Our work to define the function of Dcun1d1 in spermatogenesis is still ongoing, but it is clear from the
present data that Dcn1-domain containing genes play a highly regulated and vital role in spermatogenesis.
Spermatogenesis is difficult to model in cell culture or other easily manipulated systems, so in some
regards it is not an ideal candidate system for studying the endogenous function of dcn1 domain-containing
proteins. However, one potential member of a specific Cul3 complex, the BTB protein KLHL10(70), is
required for spermatogenesis, so this could be an interesting complex to study for modulation of CRL
activity by changes in SCCRO expression. Abnormal expression of germ cell-specific proteins and
pathways are thought to be important in certain cancers, and the very high levels of SCCRO expression in
testes may allow for specific functions which are similar to those occurring in SCCRO overexpressing
tumors.

Gene duplications creating Dcun1d2 and Cand2 may have co-evolved to support a muscle-specific,
neddylation-dependant function in vertebrates.
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In contrast to Dcun1d1, expression patterns of Dcun1d2 suggest that it plays a role specifically in the
regulation of the neddylation system in muscle, and possibly nervous tissue. Intriguingly, the tissue-specific
expression pattern of Dcun1d1 closely parallels that of Cand1, while Cand2, a close homolog present in
birds and mammals, is expressed specifically in heart and skeletal muscle.(131) These parallels support the
notion that UBA-Dcn1d protein function is closely linked to that of Cand proteins, and that Dcun1d2 and
Cand2 may have coevolved to support a specialized neddylation-related function in muscle tissue. Murine
Cand2 is specifically upregulated during differentiation of C2C12 myoblasts into myotubules in vitro(132).
If Dcun1d2 shows a similar expression pattern, myoblast differentiation might represent an excellent model
system in which to explore the effect of varying expression of Cand proteins and UBA-Dcun1d proteins on
cullin neddylation and CRL activity in vertebrates.

While this manuscript was undergoing final revision, Shirashi et al. (133) published exciting new data
about the role of Cand2 and cullin neddylation in the regulation of myogenesis. They focused on the effects
of Cand2 expression on the protein levels of myogenin, a transcription factor which is rapidly degraded in
undifferentiated myoblasts, but which accumulates along with increasing Cand2 expression during
myoblast differentiation. The authors provide evidence that ubiquitination of myogenin is dependant on the
activity of CUL1-containing complexes. Interestingly, transgenic manipulation of the rise of Cand2
expression in differentiating myoblasts has a direct and logical effect on myogenin levels and the rate of
cell differentiation into myotubules. When Cand2 expression is suppressed with RNAi, myogenin levels
fail to rise and differentiation is delayed, while overexpression of Cand2 conversely stabilizes myogenin
and accelerates differentiation, an in vivo recapitulation of the simple inhibitory effect of Cand proteins on
CRL activity in vitro. This finding is exciting because, as previously noted, in vivo manipulations of
neddylation pathway regulators such as Cand1 and Csn5 in other cell types have either had modest effects,
or resulted in “paradoxical” inhibition of CRL activity following either RNAi knockdown or
overexpression of the target gene.

One possible unifying hypothesis from these observations is that the neddylation pathway and its
protein regulators, such as Csn5, Cand proteins, and Dcun1d proteins, serve a “housekeeping” role in most
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vertebrate cells, with constant expression levels which facilitate CRL activity but do not dynamically
regulate ubiquitination in response to cellular events. Instead, this regulation is carried out by specific,
dynamically expressed CRL components, such as F-box proteins or other substrate-binding proteins. In
specific contexts, however, such as muscle-lineage cells, or germ cells, the neddylation pathway may
become a “limiting factor” for the activity of some CRL complexes. Thus, alternate neddylation-pathway
regulating genes with dynamically regulated expression (such as Cand2, Dcun1d2, or testes-specific
alternate Dcun1d1 transcripts) may have evolved to regulate CRL activity in those cells. The current work
provides initial but promising leads for the exploration of this hypothesis, which must by confirmed by
functional studies in vivo. If further work confirms that Dcun1d2 is specifically upregulated during
myogenesis, it would be interesting to explore whether it specifically enhances Cul3 neddylation (in
keeping with our in vitro data), while allowing the activity of Cul1 and Cul2 – containing complexes to be
suppressed by Cand2. Such a phenomenon would have logical appeal, since many of the known functions
of Cul1 and Cul2 complexes involve cell-cycle regulation, which would be unnecessary in terminally
differentiated myocytes, while two of the best-characterized functions of Cul3 involve regulation of
microtubule polymerization and modulation of hedgehog pathway signaling, both of which are critical to
muscle cell differentiation and maintenance. The effect of Dcun1d1 proteins on the hedgehog pathway is of
particular interest to us, since our previous work showed that SCCRO-transformed cells show highly
significant alterations in the expression of several hedgehog pathway genes.

The oncogenic role of Dcun1d genes – future investigations

Our original interest in DCN-1-like proteins arose from evidence that DCUN1D1/SCCRO is a geneamplified, overexpressed oncogene in human squamous-cell cancers of mucosal origin. While cancer was
not explicitly the subject of the current study, our discovery of four additional human genes with many
similar molecular properties raises the question of whether they might also be candidate oncogenes. Further
investigation of this possibility is warranted.
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Returning to the mechanism of SCCRO-mediated oncogenesis, our hypothesis that dcn-1-like genes
serve a “housekeeping” role in most cells and a more specific, expression-level-dependant function in
others, raises an interesting question: do tumor cells represent systems where the ubiquitination of critical
factors is controlled by the expression levels of neddylation pathway proteins? Frequent overexpression of
another neddylation pathway regulator, CSN5/JAB1, in several human cancers, suggests that this may be
the case.(134-137) Since some expression-regulated CRL components (e.g. Skp2) are stably overexpressed
in the same tumor types, common mechanisms of CRL regulation may be defective, making neddylation
activity a “limiting factor” in CRL activation and cancer maintenance. Such derangements may identify a
class of cancer patients who might benefit from trials of existing drugs, such as the proteasome inhibitor
bortezomib, or future drugs which specifically target the neddylation pathway.
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Appendices

A:

Unique identifiers for Mus musculus cDNA clones used in this study

Dcun1d1:
Dcun1d2:
Dcun1d3:
Dcun1d4:
Dcun1d5:
B:

RIKEN FANTOM3 ID
F630119O03
F730211A17
F630204O15
9030622J04
3110001A18

Genbank transcript ID
AK155081
AK155726
AK155160
AK033559
AK013933

Genbank protein ID
BAE33033.1
BAE33403.1
BAE33084.1
BAC28359.1
BAB29066.1

Genbank identifiers for other representative Dcn1-domain containing genes2
Genbank transcript ID

Homo sapiens
DCUN1D1/SCCRO
DCUN1D1(Ex1ab)
DCUN1D2
DCUN1D3
DCUN1D4
DCUN1D5

NM_020640

Genbank protein ID
NP_065691.2

DB095571
NM_001014283
NM_173475
NM_001040402.1
NM_032299

Mus musculus
Dcun1d1(Ex1ab)
Dcun1d1(Ex1abc)
Macaca fascicularis
Dcun1d1(Ex1ab)

Genbank EST ID

NP_001014305.1
NP_775746.1
NP_001035492.1
NP_115675.1
BU946323
CN842488

AB169138.1

Bos taurus
Dcun1d1(Ex1ab)

BAE01231.1
BC102675.1

Canis familiaris
Dcun1d1(Ex1ab)

XM_843562.1

XP_848655.1

Danio rerio
dcun1d1
dcun1d2
dcun1d4
dcun1d5

BC068381
NM_205538
NM_001032366
NM_213331

AAH68381.1
NP_991101.1
NP_001027538.1
NP_998496.1

Tetraodon nigroviridis
dcun1d3

CAG04390

Strongylocentrus purpuratus
Dcun1d3
XM_001192744

XP_001192744.1

Drosophila melanogaster
dcun1d1l
NM_140520
dcun1d3l
NM_165963
dcun1d4l
BT012470

NP_648777.1
NP_725244.1
AAS93741.1

2

Gene symbols are those used in Figure 3 and throughout this manuscript, but may not correspond to
current NCBI nomenclature.
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Caenorhabditis elegans
dcn-1

Genbank transcript ID

Genbank protein ID

NM_065465

NP_497866.2

Saccharomyces cerevisiae
dcn1
Z73300

Q12395

Dictyostelium discoideum
Dcn1L1
XM_630829
Dcn1L2
XM_633496
Dcn1L3
XM_640290

XP_635921.1
XP_638588.1
XP_645382.1

Arabidopsis thaliana
Dcn1F1
Dcn1F2

NP_566436.1
NP_563983.1

NM_112112
NM_101454
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